ࡱ>  F- _SIw ?W.nJFIFC C    c !"Qa#%BC1ASTb$2c&3Uq4Rd'5De Ew9r7R!QaᒡA"#1q23b ?(.߽~'U?E[XtI-5ç ]㧺 5J*TX\:qV^z :P^z N:OuE+Xt᯽C4C}"](h?A_]87h?A_ƕӆ~Ut_ѠN+?EuAſ$8xƕӊ7'DZt~"ܟņK<{wrO_M?=?'vEŷ?'n߈amnOݿ~mnO Гx#vC[x#-<5 Гx-<-ߡ'DA-ߡ'Dnx$muCſ$" ڿ?x ܟn?x7'Dn?x7'Dn?xD-'&n?y~ /[BOnwBOA?7;6 /}ͿL7;?(?A_x߿y_? ܯ߼~ ܯf~? }LyDn7ި?A_eѾ~A #pAM? ?74?$o~?hA_`F}T?{JDWf?"?g^z }p3]{_ ^zf?AT_gʋL5ׯިA_ t?jT_?쨿A_k_Q~ao?Q_uG&5Q~~ e/0WyL ]/#Wx_0~I/03Wx'?x`]Ot5wިA_`fap6~G/&5wިE[ ]Oot߭e]{o .jo Ot߭EO&`mSx'x#Qv[L&j.߽~D ]{o"/x`Z/x`L_E[ tߢ߭3{o >k1K-)3]s77x13]{obfM-13{o &!{t߭a" M=_o/x` t[0b97xa1 t)E[!7x`75o ߢ߭Ob[0bE5f?/Kut⚷!$Ri?Yk./_o u"Ik.O_ ~OqM?[iҍ?'x:p#i*qOi4ӣӏUu!Oq^N?Uӈ]?7+nBJķ_ஜKuCNKvqIv+NGvc[Us9xȿ[I"oe.q8[AݧoPRo?x[N?Vwӏo[?N? enqr?Vwӏqwӏ%Vw#oI[@Eny8[VwӏD-?x+uȺq S?x>??Ĉ0?"@ߧ"N?O8OoqS?ӏ?&ϴӏ_#(i_)>?ğӏ'<ܿOdOTqI?[7/IfF~W">bI?[/G1oODܳioO}@ߤAK ~~K?I?'x_[ioO"O'sߤs %&@ߤ}[icx ɹ_M *//l-DAqʿy_cqߤAqʿln?W**U?/_ ޿*Ĕ4Q~ɩ?I?o5OoUO|?+I .W0/>4^+N?:q~獴 G,4M:VXsiӋuajH|R/WV/aԋņH0X|Xj*o|?x#⨏#|gx&$G$mB AD|Cx # &I$G|~πmP7/&x>π$uFG, Lj!o??O"#<<X<_x#'ǧ> 2=?0< '(?W #g_d~~A?> GgAW|83## _??W|Do?>"_?? 'o?x?c@?x!xAoOECφ-!ȷ&-\['Ű-aql m`l}G`Ű"sŰba?Ű?~ [g-Ű޿- ׆-6x[bN [-h/1la_xb1l'ql9? ["0>4^+N?:q~獴 T_suY9??ѫ3>]v7cL0M:VXsiӋuajH|R/WV/aԋņH0X|Xj*o|?x#⨏#|gx&$G$mB AD|Cx # &I$G|~πmP7/&x><cO"?2ȏTmO=?x"??Oz@G O@> 2=?0< O 'w?W|?xH#? ?O?Ax?W"_xo1 A<1 OO< K|![?`Ű Cx+EN?xN>,5~oT7> IITG|eox>3x#6! ω"> GGxoxψ ox$#?gA6 I P|U" O73'__}`Ű~ [ O1l?}`Űqpxb1l'ppb1l?Qx:Һx:41DJ6F?GLjKi:'0rEMAYKTdP56=$W3m[ )_D?8oOjUO e 9s>y#Ǜo\~73NeL]1鏗Tii&mt'FD~a?Q?3~z|~sy~纑VXsiӋuajH|R/WV/aԋņH0X|Xj*o|?x#⨏#|gx&$G$mB AD|Cx # &I$G|~πxa%$GYA*' > O_x?Dc''#Jz%tπ# 'OO_Dc f?L}%Bf| [-?~-| [-[`%5b?kql濯^ 1l-L[g_ql,E"?obIa_x[b o`fO#ZA-Ű yo`FN`M'_ [2`m/xbL[2-ZoŰb oTb~?aqs [-`Ű'A^ [ ?Ώ [S`ź_EaRWR/Q;/>9=#kӧczӟ~85&?鎿?ʳ۱ʱ0-0#;lc𝗟_1[椊0ƶ䳦|l4O?o1?#F۱.峢HL~77<ھwfkFB])?xv׵lgs 6r~ƏY-d~=>_S)U$ r*? g*?- og7oD|F$ $$A7?oM ooDwG_g~(>+C?cdtǂo? /"mO ?x?c<M? # $2?(I?"> `%_e_l޿-n)oKkam ?^C/o߁o K$?b&-灋`fO`&OobKq_xl~?|`Ű6~?L_ |[2{ob`?1l.-G}a[2-\[3 ڏbL?}b1lj?xqsqbgqpxbX`-?t?GO-Ű3Q;Űbwu`Ű#ŰbA/tW<g-źQ( |1lJMX?.-~͇RWR/V42 ˹539tӦuN!MUp$"Ьxwƿ>ն8??䴴9>#ͳ҆(ϧ?>7_ނo6ᨿs*R*L龱c2٨_ԗԖ.*wɰ">b_oᱱ="۰³ᴥB!U6<\y.-']ܒ,vYsIk\`vS(?w?`ÕM__eB/-=SckRnQS:$a@]xl\jc a~W7~G1XhQlןķѳSmPҔ]Ū(|0~ɏw? !()'4;šeEPOUC~;AOG(W\&PMcㄱќ$+l.~+څ暿[A%)mƎ܇jYbe]1⪿-x$_%{@]RoVL#jkSZyɑknt9L?go'o_--^OBw;"UcȱGO*aQ̑&OS"npo73?7"> #o^ |7&7 A$G|~πm"?" Dnj?cR7 ?A 6o|op!("|U=|D>c?AQ?A?Q޿|_|BF[k[fx._/o߂?߈-7_WAo['yb1l ?_x [i?!o̟狋`2|1l$~!`&_Z_Ű3(&-LxQxEX`aO1l&-s`Ű~?Űb~?x [39ŰbO91l&-_|?.-b1l ω`ŰGW`Ű6^?^&-Ű#R?_-Z1lHZ [ t#aqny [-ғT?o`źQ, Ϗ [-ҏكX?1lJMg=a`źRk?I-~͇RWR/VI#P|>,K;1+S˓ޒ6w}n𱏲?c?0<|S t88>`AnWŧTĶem-Ke%lJbHkSKNՙDѠ=_Hj - E6_،Q41,uP`y& AO-o?1.Mi##-5Qᢨ$tp:wCY/_c/F w_U쑭-IfmeHNHFl=("$>"m@MMIQ 2I4''/ /e~׀޿{z_/!_E?~"߀%B/ob?oFOŰ#'m $Ű'{ ?3`&_{`Ű&`?-1lX?O |[2o |[2F-1lGbM9ql.-lja1l91l&-ň" Ows`ŰP?|L[ `oQ:?1lj?׏^ [5 [-H?~ O<_`Ű#S߉`Ű&G`-T?g`Ű&G7ŰjŰb U}`źBjt b1n{-I# [ Gth?-A$̼1lIÇ3Ű~ԇƕԋiՇ<N/X!ۡo󚕓'Oq:C^OAxo;¿Uu_WQ9&wXd8eR:cϧ'9ļw[v~Z'?(6n__ ֟m<DZ8E_sύL~p?"/B~ZJf@2x~K?'>!TS vʕi#FwS$v#Ʀ<;_q%[$q?ZE#UFa6]Rf<WF?M?޿f\* )-K_nxF_KSTn_]:şWƟO"{]ƾY ?L`\?c[fNC_ɿK/Y⡏{n꫍tUrə$v$>+Oꁿ"O^so~Wǎqmvm-Caa5)mOk~~O k?]?./:Ĕnc+M "1 I=c'd3j,Ii"c訊?oGmN_,߈dOBĿgv)'rhrvm [?ʿ@S-uO[>òѰ>=ꊖ2;*&ٱ}|@n?'/=c?@?oQ?[/2-"?k[ Y?^*?~#6 ~@/߁oo  d?_x2o&-b O;qlŰL[5ߏ^Ű3Q߆-?b1lԏ߆-ڤ  [-=ŰH?b\[j$>?|L[ G7ŰcP|x;Űb Uql.-5`?b"5X?t$<1lbL[mZ?#c`ݷHfHxb7m҃\?Cg`ݷJ?gPxb]t׏Xxb1n~5Űb(7xm`ź_Essu!u"ZuaӋ$> # 2|gx 73># ?gO_DcM ϊc ޿_AB?__|@Nߟkno_3z_%^ ~"~(&~߀km'y 1lL[8/< [i??_2o{ɋ`&_x( G}~ ooLGfZ?x<-1l91l >%I`-Q;Ű&^jo`f~?x[byH:?-1l ԏo`&?ŰZGGb G3`&G [EUC-P?xbL[j(H [j(H [5X?1lcX?L[ ` ?!1n5`?`źDգ`?>&- 1qlHZ GŰH ҇t(1lH҇n5x?-v#5x? [?cm`źPn#t܇?dž-AHM [-ҏiN [_訿7nn>4^+N?:q~獴 G,4M:VXsiӋuajH|R/WV/aԋņH0X|Xj*o|?x#⨏#|gx&$G$mB AD|Cx> |=< #>c2>*'?GAo_[-[-!o_!`LߟkRE~ 6?~Koo?߂߀3'AcO(#'_yiGdh?Om/K|eh?O'`f_}[~"[7-hs 1l?}-DžF-Sqa1l< [iWsb xws&-4 `MP?Ώ$ŰQ׆-K|Z [-5H?#Hxx[bŰW<j`-WCbI`-WC\[j,H&-ŰV??`-X??""-5g=a`ŰX?#a`Ű61Űbyh?-Ű#\?#e`ŰG21l&-\?Cg1n8J?t($> # 2A 7 ?"z~>Ag/ _"O | 722ޣT,޿[x-[er /o_ߌ2"k~,, $爂gy2~~_xG{?_ L?{ |G} }2 Z?O&aQasFoǁooǁoFqTxAi?>-׏>-׏>&-Ű#P?-\[5b ^?xbL[j[wO<~ G`MT?ga1lu#l,E&1l&-zL[ `MT?.-ۇa1l b1lՎc@Űb0ŰbVHxL[Ű1Űb$|1lkI/bVW"-"WPb1lPb1l JO [-5x?-Ű#^?ckaqn5x?a[?,ͼ\[-@KotŰb!7xo]tC_qa1n9ŰFtCGn5cpxbMtcӇn;ŰnۥA<<1l.Pnv7m҃uxI~7}҃w7}CEf'0EfO]ZtZtWJ;%](}?UN%>_qr3jgҦ?);8u_x=^׵?TnGtޔŷ N3W:ס.k&ۯi#1M7/7 ImDN7QsAOnX;SC:9ivp,ɌL~!z:dkOnBY*Qu9_p Ps9u^i{N-(NϥLu<}qSsgqۯm=GSp$).Xg'C]<]~~zG^ߔS>In,DN09Πw5u_k{^t?o;Crɍ?azt ~~zG^ס+* HrKwy83FuuG__HYt?vs,ɍ? az:duG_wk{_?L)':?.a6 z :(ߕ$S0@YO͞FY~ ݯu_ ~V +$;:oJWq՞pr5KuG_G^'Mo&d~9%]H09ΠοHnm}#kgC"N?{fLl]1k n$3:_HڟP?TODu N\lT$ 99#􎽣oߕp LT]e?6zz~ ͯu_f_?Dޔ{'=IkO:~<'InB"o'09Π?H_Hc3Ӎ۵ȳ&2]1k n$?:_Hڟ۷P?V~Ou NlT$ 9u9?Hnm}#h\G+7@ϥL<SkgqG_sk{WpxUDޔk'=IkO􎽡T8f~9%8sFuG_zG^?+hn"Y1t0CL?Hx{OHڏoP?WOu N\lT$ s~״m#(jwҦ>)58#=#jls/K;Hҕks8k=zuOk{B?TqMF2?.dD9#:#}#kĿ!~nnE1t0CLƿHx{_HeK{[Mꄟ]=?1Χ>~k{D߉?*9\J}*`?bHs,OC#,k m}#jU3p )_ƗKsp? g g?~ k{_MKvq%.7u7p~ k{_=S&H'􎽣kPG3ɏ`L?)78w__zG^~xm Dޔ;']IkOw__G^Ћ@qC#/DLq520s 7uu<u}5PgC3 N?+fLdcסæHnx_Hڟ`uGR&uBON?1Χ>:*9Ͳ*?n댲==䌌u±< uW'P¿np8Rz89s__6״??* S1 $"o'09Π6׵~Us:ɿ^XY.9u7p:mQ&߀u N\BlT$ 9u96״L*|s9~ N*a?.A̲==C~~G^~T+<)nXg'C]<75u8}uL)G_ۅȈo?d`P@nk:*7-8n1t0CL8}uG@?!H:7=oQ $7l21P@nkp_Hh?*8n.1Ø`^w!pOn?*PG0I7Ass6ۯhR{$53S]qezdfxz6ۯjR2/&q8[O^#_xxz6ۯhco'Q $10ApOnl<·~Zp d02Cᶞ׵>F#s:'羱_N<-~~i׵SLm<Ssgqۯ=#jS3po&\q8\O^#_xxZ6:Y?)8~rKny8#:8]^ ~?fLl]1w n$O _i׵?y0ԏb:?6vz:xZpOnoߕ NCe??6zzxZpOn~TL++q8\O^#_xxZpOn~SZ8~rKmp?Fu K3 #hm̘t0CL_v{SVL#s`:'i_CN|O_u~sXjwҦ?);8C{uYP3pΛҕ[p8s=zm=LhC#$ˉ7^n:C{u}?*@·GX&2]1w n$<~8M^)SG-I;AsN|<~Ni׵ 7#J⻀xs,OC#/_i׵ʉvtޔˆ'IkO__{u+7C@GImw"c09Πu_{X:iv^Y.=u7pkۯkLK()ˀMꄟý=?1Χ>kۯh'@G3S0~ڮ̲ÿ==C_i׵_}P2&18]O^#_xxp{On)8rKjy8sFuߓʎgC;W-8ݡזdK?az:d=?)UA, PwS_ i׵ <s?hjwҦ$2zdekm=M)^'%zRg'C]<< ~8-^,ߵo"I%\8sF3_ i׵L*|;Cj,ɌL~:?t_ i׵eL&GR]xMꄟݤ=?1Χ>'=&_ ~ NTh2~l=22_v{WE/ )_Ug'C]<8}~8^Џɏ,ߵBIm7"casA=T3:Ÿv\YL~:?t_i׵?UK& GR=UxMꄟݤ=?1DÇC{u~J)9\(ezde=)n1)zRk8]O^#_xpۯhco $109Π_v{UDgCWg-8ݡdK?az:dQKo@) ?H=z~cN|8}~8^ԟW8G3¿S0̲ߛ==C}~8^/8¿?;:oJWM~'IkO_i׵LPjS(kJT n@1Up? RNUr ڮ$ 5Hl@:t".R ۸W)cC.t?R 9G,&KY3̝ <Hf^"P_ʻC1Ax0eg(5 )5֥BȀl*i۷ ᘋ*|*mWG E6@ {psVV)?msʔ֡:rFBzO%cN݆ ?LF$|/s v(] Fe]塘qˠRrAm~2fj kRd@64AېpEXLTӕt܂ "MR 89+ 69JXP˝9#ԡ='v bi 'or&G>Yȇo.DW2{d9 6? Y3J B r tP  bvf"ʬ&_@iʺnA[U„@ ^UOwr,oCeΜPG;hk14zaBOG#щ,CݷC"QW~yhf=r2T@to Z9ZԨY M1P@;v3eV/ 4]7 BH`Tw@b*'ͻuz9R7?2NH(OB #rdlqC=|ܡ'#ɑďear!n (̫<39t*NH y V ҃PBC]-jT,¦ `r jrVtp$P0iCd׻1earf:Kjs$a'9a2_M68dnPbG207mȔjUߞZw '$<+?iAVN@*DaSLT0ݹw YU5H 9WM+j8P(4!I3n^T~ Ӓ0JЂm/f&P_2v7(Idz1#{\~BdJ5*- ǻ]Jnm4+P PKZ "*n܀;b,e~](I juEYX\qίG*R?Z\~ A?sXLM(g;v$y2=̽.D? xt2%w疆c.%I7A`PjS(kJT n@1Ua2? RNUr ڮ$ 5Hl@:t".R ۸W)cC.t?R 9G,&KY3̝ <Hf^"P_ʻC1Ax0eg(5 )5֥BȀl*i۷ ᘋ*|*mWG E6@ {psVV)?msʔ֡:rFBzO%cN݆ ?LF$|/s v(] Fe]塘qˠRrAm~2fj kRd@64AېpEXLTӕt܂ "MR 89+ 69JXP˝9#ԡ='v bi 'or&G>Yȇo.DW2{d9 6? Y3J B r tP  bvf"ʬ&_@iʺnA[U„@ ^UOwr,oCeΜPG;hk14zaBOG#щ,CݷC"QW~yhf=r2T@to Z9ZԨY M1P@;v3eV/ 4]7 BH`Tw@b*'ͻuz9R7?2NH(OB #rdlqC=|ܡ'#ɑďear!n (̫<39t*NH y V ҃PBC]-jT,¦ `r jrVtp$P0iCd׻1earf:Kjs$a'9a2_M68dnPbG207mȔjUߞZw '$<+?iAVN@*DaSLT0ݹw YU5H 9WM+j8P(4!I3n^T~ Ӓ0JЂm/f&P_2v7(Idz1#{\~BdJ5*- ǻ]Jnm4+P PKZ "*n܀;b,e~](I juEYX\qίG*R?Z\~ A?sXLM(g;v$y2=̽.D? xt2%w疆c.%I7A`PjS(kJT n@1Ua2? RNUr ڮ$ 5Hl@:t".R ۸W)cC.t?R 9G,&KY3̝ <Hf^"P_ʻC1Ax0eg(5 )5֥BȀl*i۷ ᘋ*|*mWG E6@ {psVV)?msʔ֡:rFBzO%cN݆ ?LF$|/s v(] Fe]塘qˠRrAm~2fj kRd@64AېpEXLTӕt܂ "MR 89+ 69JXP˝9#ԡ='v bi 'or&G>Yȇo.DW2{d9 6? Y3J B r tP  bvf"ʬ&_@iʺnA[U„@ ^UOwr,oCeΜPG;hk14zaBOG#щ,CݷC"QW~yhf=r2T@to Z9ZԨY M1P@;v3eV/ 4]7 BH`Tw@b*'ͻuz9R7?2NH(OB #rdlqC=|ܡ'#ɑďear!n (̫<39t*NH y V ҃PBC]-jT,¦ `r jrVtp$P0iCd׻1earf:Kjs$a'9a2_M68dnPbG207mȔjUߞZw '$<+?iAVN@*DaSLT0ݹw YU5H 9WM+j8P(4!I3n^T~ Ӓ0JЂm/f&P_2v7(Idz1#{\~BdJ5*- ǻ]Jnm4+P PKZ "*n܀;b,e~](I juEYX\qίG*R?Z\~ A?sXLM(g;v$y2=̽.D? xt2%w疆c.%I7A`PjS(kJT n@1Ua2? RNUr ڮ$ 5Hl@:t".R ۸W)cC.t?R 9G,&KY3̝ <Hf^"P_ʻC1Ax0eg(5 )5֥BȀl*i۷ ᘋ*|*mWG E6@ {psVV)?msʔ֡:rFBzO/끇IJ4j ."BrAm RJZP RېseP 2ԧ&-7g$6T[1eetzycI>!o3PMHÜ'|r\LhgOAty2X|p0@4F|>A1%R(NH y #!djUSPkJTaSJW `r;.b,dfZԥUʂ׻ f" NO,ti'-&j sO9ێB  h.1O&Wыu(&(O:&$R% 7A$d, J*rjiBJl*iJ n@eEC LRݜjP@:dulU!)厍$A6B#rP G;qAq3O<~?i1aν@ҥIS5ėJPd9 6䌅AVNMCݭ(@IP M)\v칈aijSRTSMT*^2:=<Ѥ&C$aJA>9.&43'ՠ<_F,>Y׸xtTI>pf)J '$<ܑ5*ԩɨ{ *+0ݹ1U 2 3-JrjRvpJjieAݐճVPXxG:45d9Bp'!?{H+Ň:Ji'L\E)Aے2AZ95v%@64r۷ "ʡAeNMJZnIP M5Pl {:b*F|B߂f! 9(N# p?Ve}g^ aiR$}ébK(2P@trFB ԫR&֔ $¦@;vv\YT04̵)ɩKM * v@VEYBaXO[Ld!0% $s4] cL, !o3PMHÜ'|r\LhgOAty2X|p0@4F|>A1%R(NH y #!djUSPkJTaSJW `r;.b,dfZԥUʂ׻ f" NO,ti'-&j sO9ێB  h.1O&Wыu(&(O:&$R% 7A$d, J*rjiBJl*iJ n@eEC LRݜjP@:dulU!)厍$A6B#rP G;qAq3O<~?i1aν@ҥIS5ėJPd9 6䌅AVNMCݭ(@IP M)\v칈aijSRTSMT*^2:=<Ѥ&C$aJA>9.&43'ՠ<_F,>Y׸xtTI>pf)J '$<ܑ5*ԩɨ{ *+0ݹ1U 2 3-JrjRvpJjieAݐճVPXxG:45d9Bp'!?{H+Ň:Ji'L\E)Aے2AZ95v%@64r۷ "ʡAeNMJZnIP M5Pl {:b*F|B߂f! 9(N# p?Ve}g^ aiR$}ébK(2P@trFB ԫR&֔ $¦@;vv\YT04̵)ɩKM * v@VEYBaXO[Ld!0% $s4] cL, !o3PMHÜ'|r\LhgOAty2X|p0@4F|>A1%R(NH y #!djUSPkJTaSJW `r;.b,dfZԥUʂ׻ f" NO,ti'-&j sO9ێB  h.1O&Wыu(&(O:&$R% 7A$d, J*rjiBJl*iJ n@eEC LRݜjP@:dulU!)厍$A6B#rP G;qAq3O<~?i1aν@ҥIS5ėJPd9 6䌅AVNMCݭ(@IP M)\v칈aijSRTSMT*^2:=<Ѥ&C$aJA>9.&43'ՠ<_F,>Y׸xtTI>pf)J '$<ܑ5*ԩɨ{ *+0ݹ1U 2 3-JrjRvpJjieAݐճVPXxG:45d9Bp'!?{H+Ň:Ji'L\E)Aے2AZ95v%@64r۷ "ʡAeNMJZnIP M5Pl {:b*F|B߂f! 9(N# p?Ve}g^ aiR$}ébK(2P@trFB ԫR&֔ $¦@;vv\YT04̵)ɩKM * v@VEYBaXO[Ld!0% $s4] cL, !o3PMHÜ'|r\LhgOAty2X|p0@4F|>A1%R(NH y #!djUSPkJTaSJW `r;.b,dfZԥUʂ׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|rq@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f"~3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:EGGu3PLIqJnnHYjd=҄URʌ)۷ "ʡ 2ԧ&-7g$6TaN[1eetx&9-LsO9ێB =xZ ~ɕb{UyO:&$R% 7A$d, J2rjiBJl*JFېsePijSRTSKT*0^2:<GGj e9Bp'!?ў<~?i1aν*q@<'L\E)Aے2AZ95v%@6Tr v칈`H4̵)ɩKM * Sv@VEYBb C S5Ą28v㐃{p?Ve}g^hthj ."BrAm RLZP RQ;vv\YT0$fZԥʌ)׻ f" qN!bBbrP G;qAOgOAty2X|p \P:O4tqS5ėJPd9 6䌅AVNMCݭ(@IP U)\r;.b, 3-JrjRvpJjijeFݐճVPXGhBA1! 9(N# 3'ՠ@<_F,>Y׸Z.(':8}ébK(2P@trFB ԫS'&֔ $ªTaNݹ1U 95)i8%@54A uو(C,\S4tq}ofX'|ro~] cL,r|>A1%R(NH y #!djUPkJTaUJW*0n܀˘*LRݜZQ:dulU!.):8>з3PLHC,AJA>Hn97i h.1O&WыuVI掎9>pf)J '$<ܑ5*ɨ{ *+Sn@eECAeNMJZnIP M-Pl{:b*Mrh[&$! % $sߴF{H+Ň:ތhb]-kI rvf"ʡ9](Y M5@l:t"K2:Hm3- dnI %c6wzӻaBOG#Ж,?qS"RZ\㐨RrAmoF BI$EE9\@;vr3ePNVJ[.,6@{sVP}$JEs6c2GROG `f;=|ܡ'#ɑKeid)c C.KTd9 6WZ$؀KZE"@ r9aeN@-F DSMP aN9(AL%"CE1™#۩Rp'X3MើtnP%24p2TȔw֡%*2T@tn+уPl@ku "QNW ݹYT0@Ӳէ Rˣ " 0^vU ixGI\͡eLԩ8v~_:w~7(Idz{n8*dJX»P˒r*NH y BV6 5ֺ@Ȩ+n܀Fb,~ @ijӐ)KeтTSw@;Nb*oS#Hf2LpHT V;hl gxg;v$y2= a̽C 7 2%,oa]e~9 '$<ۡ `+Dk]BHdTSn@#1U ? 4iBȀjid )׻1e7^)DW?hqh8S${u*N+߶i3Ν߻ <f^!J702FJnmЅ{z0jM t$P2*)۷ *vZ Rt`d@54Ә/"R+ٴ8̴S)='|?o4N݆ ?LBX|/pCM%LKW}jr_B%I7AB5 &ZP(rېEC ;-Zr)l0P j uiEYB dt)fZ)JA>Jm7큚l wr&G,>Y~!げD+ /!Qt!^ތhb]-kI rvf"ʡ9](Y M5@l:t"K2:Hm3- dnI %c6wzӻaBOG#Ж,?qS"RZ\㐨RrAmoF BI$EE9\@;vr3ePNVJ[.,6@{sVP}$JEs6c2GROG `f;=|ܡ'#ɑKeid)c C.KTd9 6WZ$؀KZE"@ r9aeN@-F DSMP aN9(AL%"CE1™#۩Rp'X3MើtnP%24p2TȔw֡%*2T@tn+уPl@ku "QNW ݹYT0@Ӳէ Rˣ " 0^vU ixGI\͡eLԩ8v~_:w~7(Idz{n8*dJX»P˒r*NH y BV6 5ֺ@Ȩ+n܀Fb,~ @ijӐ)KeтTSw@;Nb*oS#Hf2LpHT V;hl gxg;v$y2= a̽C 7 2%,oa]e~9 '$<ۡ `+Dk]BHdTSn@#1U ? 4iBȀjid )׻1e7^)DW?hqh8S${u*N+߶i3Ν߻ <f^!J702FJnmЅ{z0jM t$P2*)۷ *vZ Rt`d@54Ә/"R+ٴ8̴S)='|?o4N݆ ?LBX|/pCM%LKW}jr_B%I7AB5 &ZP(rېEC ;-Zr)l0P j uiEYB dt)fZ)JA>Jm7큚l wr&G,>Y~!げD+ /!Qt!^ތhb]-kI rvf"ʡ9](Y M5@l:t"K2:Hm3- dnI %c6wzӻaBOG#Ж,?qS"RZ\㐨RrAmoF BI$EE9\@;vr3ePNVJ[.,6@{sVP}$JEs6c2GROG `f;=|ܡ'#ɑKeid)c C.KTd9 6WZ$؀KZE"@ r9aeN@-F DSMP aN9(AL%"CE1™#۩Rp'X3MើtnP%24p2TȔw֡%*2T@tn+уPl@ku "QNW ݹYT0@Ӳէ Rˣ " 0^vU ixGI\͡eLԩ8v~_:w~7(Idz{n8*dJX»P˒r*NH y BV6 5ֺ@Ȩ+n܀Fb,~ @ijӐ)KeтTSw@;Nb*oS#Hf2LpHT V;hl gxg;v$y2= a̽C 7 2%,oa]e~9 '$<ۡ `+Dk]BHdTSn@#1U ? 4iBȀjid )׻1e7^)DW?hqh8S${u*N+߶i3Ν߻ <f^!J702FJnmЅ{z0jM t$P2*)۷ *vZ Rt`d@54Ә/"R+ٴ8̴S)='|?o4N݆ ?LBX|/pCM%LKW}jr_B%I7AB5 &ZP(rېEC ;-Zr)l0P j uiEYB dt)fZ)JA>Jm7큚l wr&G,>Y~!げD+ /!Qt!^ތhb]-kI rvf"ʡ9](Y M5@l:t"K2:Hm3- dnI %c6wzӻaBOG#Ж,?qS"RZ\㐨RrAmoF BI$EE9\@;vr3ePNVJ[.,6@{sVP}$JEs6c2GROGc?P]O}jy! 0c?x|׵_B~Ql+8)P3ރL~n)ÌN/_,uH(_p7/;cGXg!: i3W/x|׵A~Q8lGR?F6|#9N@`5r{U?4~y-~֡z/??sK\{S(.'>5lumd~u1qNX/Kٔ b0za1_~r^'3D,? lu αc^7C tӑN_9ci ,CoQM'|pld?~s8|vhwYO/-4ao5)?өsK#_,u_iWi]SU}+! c.#_,u2?w: G^6vn?Ff_ɟ ~̧_ėVa3_􎽦ז>ҥ_X~~Ƀ:ǬX׍!: i_u],}],CSI?k##9N@`uG^{kT@;kLaoė=j~3 q&:^XV)Pd_=ϒ:2?w: zG^;^X^(fO @)[0za鎃u6׵s只ԉk(B*lu[X8C tӑ/􎽦v~S{e~ i;uRqr?9 OHڿOFMH8)X[-Z8_9p i{OrUX()^/v~zu􎽧tSٶ;#ٔ3ރFzcuNOH;O?/`j؟0vQeu?s`:O a~I4g)I2: u?˧|6L;aoķ]jk6-u?˧ *a/oot䇻ll? νF2AxOHڙ_=P;6߆%32Y{~;O.5:&:只_DMg;#\bƼn 1g;NF&:?6,_oi2f)q1;g󃜎zG^;^XXP{pRKZ}׿?sK]~׵7vos䇻ll?νF:6״;mc]8)%Ug1]#=1_i{M,}]Dߵɏ;#zōxa?r0uG^{kT._eN\g:_u7O&o_J߉.Z/C? qx#i叫&/v~zu􎽩叫Mo¿>?fSK0zauuG^kWhzQ ~?&߲`쎣p5u?a?r0{M,}]kYbM4e)q1?y_u7vq3~< VGq֡zx:|7]k􎽩m9c?.J/6lH{c3{OiWkۻmOo8)Ug:xcim9chl5kw&?lUbƼn 3#XxNX#֫8{|JH{2?w: ~i{_?n_}oNY{{צ__,u<],}]~[TBߵ`쎣],kl$0A9县厽oƿ=eS?|pIس#9~iWk}iJ߄< VC_B_a3 qqcxNXC~迅?/펻 νF:5_rHojNkUY{{ :qc9c#YDߵO`펣[,kld0Nr0ur^7򻬱~~~)I󌎠#>Ӗ:q3~ 8)Z[ n }s7]>Ӗ:S+ȡCݶ61רP\NXxNXJoge:!UfA>צ?7_FӖ:, "oڗ0vGQ`5pl0A9q:~ m9cjVXi3튰K8r:8\{_\L߃< VB>}s7]jFX/`*迃 /oYvYG^AqZ~:/OfGN*³ 'aur{EM??;#WXs`qZcjPhi?c?|pjIsA9r'_,u|?ʶV=pRZ}8o8|״GQU~^/톫νF:r+_,u|_nͷo<32oJ==FzcuN'VX/y(i?dGzōxM3#^/W/^7a`͟xge:ߪY{{:q~ 厽 N&luި5pl0A9j/:(/1Yb~w킨JGHϜdu9 f_qzcj3:/OEG9pwqzcj?^/톧 νF:5r{U'f?¼32o ==z|8\^ԏ~ ~Ƀ:oTu6rcv5r{X~? i;Tx#$cg2:3W/8|׵_CSK[GgJj#8o8|׵?AR蟂/oSvYG^Aq~ 厽g^NVa=zcuNf_qzcjGBSi?dG:ōx9 1g;NFq~ 厽 VXh4`5qt' 0q~ 厽\J߂? < VTP?9\f_厽Dqx{|H{2?w: ^/_,uW}? uT* ?au5r{R?MK1&=Q,ka?r0^/_,ucP_bD0)Q┏8r:8\^M.%og+ _u^s.3W/^J ~ 8_ O$=cafzuj/:O>͟xge:ߪY{{:q~ 厽 N&luި5pl0A9j/:oaP{ ?T>q/¡|7|_CàW^Tq(Wz^TqW/zX2:4ږ+Wz^ج8B; W];ޗ;Wo=X-꿔x.wWyWeЏWx?ޟ_eO?}/,.^?(WyWxo=޿x] Wt-~Q(\QK?v(rjx.^ ZtVjr/Lͫ/* j?r/LjG!oV(3/3~x&@~QWyݫ/2Xȿ&drGeoÖ_q/*8oaP{ ?T>q/¡|7|_C *8oaP{ ?T>q/¡|7|_C *8oaP{ ?T>q/¡|7|_C *8oaP{ ?T>q/¡|7|_C *8oaP{ ?T>q/¡|7|_C *8{yO~5ásw:1ncZt#\|:O~(x&JW;ϧiu᧾;׊W˟M+]N ߂1_cɔҿ񦞓uJys)u<~tҿk߈+_n}~K+{ׂ<|ݔҿW?W^vSJ??-jjWOΧO;>=7м;鿜O*9?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstu,R$- _SIw ?W.n 03@6Lp ʚ;]8ʚ;<4dddd[7Ԝ77(7\g4.d.d77(7<77ppp@ <4!d!d[K7Ԝ77(7x\<4BdBd[7Ԝ77(7\)___PPT12 %0___PPT10 ^___PPT9@?  O   f u        vTUW !"b#$c%z&d'(e)*f+,g-./01h23i45j67k8l9:m;<n=o>p? @ AqB CDEFrG!H#I%J'K+LsM3N5O7P9QtRuSXTvUYVwWZXxY[Zy[\\z]]^{_^`|a_b}c`d~eafghijklm9nopqrSs:tQu;v<(PK!V[Content_Types].xml (|N0H+8 (8ĪVEBpֻ3iVwbl VLly Ё9!u{yL IuF^k2#z cẽN`0[mb` \!#s,Hё9}~TU 6Ul¼;{-dۡx/ ftΓCR}o v|i@T;\/E_PK! K& _rels/.rels ( 0nS=H^DtiUۛc a)hěBUrdk)Dd gIDr*dS("QlT3Q4b̜'օ9I]e3\0ťQ.D=vtr5aƓI+D#V0;f[e!/PK!tableStyles.xml I0@Ὁwh}-CQ$ +w*!@he/?JXd45ݤ{c@qqi` yߥ>\`Y{ff` R>&- {p_/̴>?" dd@,|?" dd@   " @ ` n?" dd@   @@``@n?" dd@  @@``PR    @ ` ` p>>#ʰ!ڰDzԳٱԳٳղ.泾ɱ0ᴿ+%ư(0&7ܪ&*8f;ó6VT-Vʲ԰ʨ)@ŀ< uw}l IvVNLTL3pG|ﴉ`(UoȮy=J2:88Z )9kR /Ju"(\fhnX soiɶGgϤqsJ8 `ֳ'*e$ ީ3/zPK!*8 _rels/.rels 0DnzЃXmlo0of5OIw AN{cݠv=m 838yG 6U} ShLq`L)d=Ҍ\@.;3, ;$e͂): vq}j:zɥ'k茜(f,ƁXA6\m>ʰ!‹)"!/Ѳٱ/Ѳٱ1.泾욲Ѱ0+^@ʐ;GB1|z-|$kH(OS#>'F˾/!bRwrRwH~H"2 Vn `CΠ R a WAK2U"eMNuVyPLLm:/ y]s)Twux%HQ~~=U-۪:cY͠ܫiIiIgO}A_}_~q rQ:mf8^O&]7(%c ewف\-lg Ȕ#s۬5L< O-7rCQղlk skm:lq[{A08tiYݿdEk<*X#H(˪7>wpz+jȫc~ އZSjw !f3jeHxm YjNOlW?@ک{NPnŖՠJC[:IAJ}ZM:ZfY.ePK-![Content_Types].xmlPK-!*8 ,_rels/.relsPK-!‹)"!drs/slideMasters/slideMaster1.xmlPK    (    N!?Rectangle 2 `} \ X Click to edit Master title style!!  2  H?Rectangle 3 ` \ RClick to edit Master text styles Second level Third level Fourth level Fifth level!    S    F`#?Text Box 7"  PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!hzdrs/shapexml.xmlXMo6 x-KUw瀖X E 8);CQ&H )M#rP_ A\W1 N|JLT{CJ*dʄ<ft: BނhӔ6MA(~<ѪR9ITс`q M>A*(8j*42ӹl4uݰX9 pÁͣ7CFg"mLGγ|{=En&"/b:1&Lmhݢ?Pq @X)\G-B JгCעf ')cmEzB雘 ^ld[S}GG7|XfWk+/+yʼnΙ$Y3]q;e?^G)jaL/@p p9 mᰏ>(L`F-u0; ?&bs0- 1)i&ӊTph]$F۽aعFXhpȝqТq4`{!?is44vaxYB?iӈ9G-gR?Y<*[:2])6'wEqj軭R@ U%[-"iS[ˈ9`KJ(.LX[w}yٲxB{hf=_m,rYs\7+WPf@\tn^Cy)Bg;P@S.K$,0h)YML%LSt~TKۢkbkgX&MQD~1 8 TfUa3m}1Oy1i 2]>gZBzJhkNu4puΕ>ؠYPK!fdrs/downrev.xmlDMO0 @HHXI (˦mnh* k8zֳj3^)ej@Phq_oA`i)f}y1|(`I5j 1/@)&IpdR;`q'Kk(lyy1?Vh}}5mA*0_pZ立39\(iU}633(1nUUUW3t,yuo ]˫~6ӵ#Ֆuoy^s {]wk3&)]I_ݶ!ﱼ ý;ҵCYls;ˏtZL0Oյ8N?o#,IgͤnߙxG>r߽~uG9A Rt`ΚG nH(2Xp0L="v9m{ 6ƔՀ^Y]:8H$UD[{BOeQP/N-IvuÓEP /= U7W:Rɟu9~?-*|w$/(Io eH;բ`邏z튌anWCl" GѝK<pɍBњr1d[zjXR>'%w :#fK-l(4lld0w2{L&ճjSfRѨ(KKR`6](f̷wYpjqMcȤFBc86Z#6HVL'+8%,Cs Dzꃳw,G2r;IpyݰŤ=0נ?(+o9֥ɫޢ2(!^7ztPdi-DLlgO9н)ZS@>P az3.R0=1yc]40@.O"7%0OW> ̰(5ӂF_HV>~zȽ2k%PRa7E2ղ5Xà,N;h_d幾}[تۀW  $|‰ 2gBVLEdHu6B({_lY)X\R\Êس^Bvb#C C[~A':k3基@@q]3Aq4ɭӀu~"'qonth,AWЊa1 MP&Fb~g##Yqx;F:}<5PR%,?pdx,ZUtoAa}dѽ<V#q^ tX-5}q.LBOuQ`$4{D=^עؘ/uRK:[hi NEvB3Ra#'Bx[p=^YI(GtCo0J{PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!\&~(8theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] : OPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!!- !drs/slideLayouts/slideLayout1.xmlVn7}/ Z8.qAm"}\k+.%~K?_3l).`eEr.93sZr&7)#mQYޝ]r0֨o~ɼ.fboL|B ^U-(Yi]-aP8k=_ jQٻ۲ʶV&$'Ni_W58&Z +YTr[ly˅.5UЊ+7K)Y4ssǪt| :5Pbpb{ٮt͵F"Sd:Or]A"8\b7)o$0ʍg"OJ?'﷽3ʙ7kNvzI}Ĵ;4Ucnr1͈0MƇ QR.ˆ@KjєTڮwlP"}#mvbڢЀu}ujSߍp2A?Ù{.Y=ZW 4`GeFY4=rp #b-" ̇ HZYǓ5vcz(qP^C4%Ux Fuh_Z>ٓr(؛vxХ($5,SN@chŶ.Y2y|3z&x?6 xZY`ّKB"vmلN1Op"$h\oz:aK'2u}9y*爔C^W=N$T_+5q^\m)=AQ~3Ej|U^}p<a Hօ~V3 o)fauK,J ɋ% ZV;7 N_Sܡb3(Pc AoL b#d*) 2 %xf{}7-RTr_! B$) c=5,O ;o~ D# О=:G :*8k>~Uq*JgƸss$:gXx3@S*{4܏1f1}; PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!!drs/slideLayouts/slideLayout1.xmlPKPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!@i!drs/slideLayouts/slideLayout1.xmlUMo!W@ܓGUU+ۑ6êާ,l&JJ cޛ\m;z郲fO8FF͔?O>q"5rw2wW>E j6FWWU(Z' w7U;]]}:R^+!XI "raDs9/`΁--gX93PK0CV*j c%HlKLͻ[}/Ε^&[QpVBa.Ӧ汗 ؅ƽ* 9uU'U!AvA+A+Gr%-d73; -e<1Hs>qa>p8;*]rPmdag@7`)y"Z8DB$" F.rCˈ0ɨNZs;:<1l"f:m^"p0]q#"&?*;ve8b3{-}Qh@{[uQrP2!C"Hi[D8oz|.$`s]@ႛ4W) $=z x淘=C;٧PCs<@{.]:#7<ŃILU>JAJQpNH(p }.pPHhN %^ǣɅI!6}e=# s:@5߬PW[ Pwɯ̴r}pKe]:NoQ,+Ln2Y&8HŝNmIS&h>C즺fyS^pŤ`=UE^:BkAG EL?Rz"$:P} VTXQS)˜:T?4Zg9͍c-k~K.Z) R++:9n_B۶Y&DZ`³ol2hC!+ Ŗ,oy\;6^79iWoAԈgc)sA.Ǹ?Tq^Gx WP+c e :(/NfM :?AYnxOl_b;O_7(*!؞L&WPK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!Jd!drs/slideLayouts/slideLayout1.xmlPK!PK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!U !drs/slideLayouts/slideLayout1.xmlW˒8O}bvSmjǦ; 0%Ԏ#81b6}{Cɞ*boa"i.7sTr);{2xzGIp* /ӺG*XAdvRTz~wGx<4^_ /w7%aigZid ﰔLTQcT٤x3|mAӄe0"x]),2 5b8} G(Q uH[iSդT_M6h]6 `'m;95v.a%;u`痰%l 8!$`8啚2=Jh֍.p%R=譶dnqG0?1y };ˎ1[uIuـ`Qaf&Z8FAF &5rVifW͟_ywdz㏧np1rcniۧ{ m6[=)3 J4r3z_zdwO[ Noцgt(/zs/0%|f;>C68!{MP;MպD_\}嗽 >p[٥Mf 1T#l/PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!U !drs/slideLayouts/slideLayout1.xmlPKBpuPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!aBp!drs/slideLayouts/slideLayout1.xmlRN0#-&x^VjqvClk=x\uFVahb6LYs{,D%hgU{X,zw"Z3略ʡH[܋ዼ0X>F'Fx4A!Rn|9nU R=`?9K4l X˭.C]b `;Tjl~7oYSQx0 O *42z&+ S]d_T\Y?`RXTS_[9*O3_1PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!aBp!drs/slideLayouts/slideLayout1.xmlPK`PK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!R!drs/slideLayouts/slideLayout1.xmlSn0?'s( R8m/Ill%" rJ%%%mC.|,g;z1R/WRծn_,r(ϟ6^ESI0 JyUQ7At-\xE7swZV#tj5:ܡ$cir%Y-dpg(EkYz}0qP"IǀVCNxAu"e1̰ E&0N6 1lL#'5;X|{],p/&U\-r&/&(pOQX:I~9Fe >,n\=&xAP&ҁF.H}} pQ5~-{A._vqfJ|Ü⛹B^& 4/S0u[9nB?PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!R!drs/slideLayouts/slideLayout1.xmlPK0PPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!a%q@!drs/slideLayouts/slideLayout1.xmlXے8}ߪ0˸Rf_&3S a7ݲ\T%U /Fy6BS2>/>4!كm'$bݻ'ñ<]F`Rwa=:wY&{e>Kɤ?}^qd3 BT>x8| 1`o*ޡKIf])&)ZhZl EF;)eEZR R4| 캽tۯW8HQLIz$dpԺG Vw³U%cVbX0~`Be珂h |(D1zN:YNLJ%:`D԰${}rubn:`]6bXWKX- P|I$D| m\DJ,](Sz7/TgN֊QIZ؊lO.Co]ӵiwF_/j? ?k4Mrkn̅NWG|^mz5o{ӴKFڹN^-eMAnk w:_sP5BOc#5Uw0 \~'^1ҦE<@GE!&]Y>:܇bJR i+ L$20] )Rad:}2(ckφC̘2CdTL\<0U;V/,h.fg}sI~l>lb4n[̲E=é 3`ד)O&f/0qt9SY~rZN[q[MSЬ Es0 叞Ƌ*FC bL^gn 6~lA~X.k޻riKe򤉐Ӻ_Vlˌ4[WtzxN,&ӥun\Yr49~ ?68" 3"hIXrCa痶ctBl1vB k ?lL8MX&y #:UA5P>HrmdYtvzuZv }Ħ]t9u]=dk޼mW64NkMl`[uǶz]X|z5jݔ &$`X'f+. %=e)b|zWeϲ\ +LQ]{*oe)_Z4y i`zQp"[|llб56W_1~wgꆖw5qJ|?FPK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!uq !drs/slideLayouts/slideLayout1.xmlPKk0fPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!xS3 !drs/slideLayouts/slideLayout1.xmln0WwrߒC *Tۢ>q DuvYاCJ07!wB46/8nÀI-,׫q2~3 u\g\Z**{10M8X;WkYp{[VRٲ4wiV?`S\D\.s!⭐#w߮ʶZekvR< 4\Eʘ.fRqF)INo~jVMWzL 34AyЈb8tީZOKSLxl8@v %ʭc[~>#+HwZ`o'nÙNIE9TKj.'_'6-b&|fuG+o}N[GHu}:zp0 %%IKF8LHK]nvQ9źD:ੲnv uy"xĸZa\ƕ;`6#\lrl"%DqGo^f=(aMT.^+r~qa>Hmٔ*.EcKcٲ9C#0౫4$4ˋr$ʢ"ZH~.Yoe~y}+Aу1ڗ?PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!xS3 !drs/slideLayouts/slideLayout1.xmlPK PK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!;VO!drs/slideLayouts/slideLayout1.xmln0El( vM7yrlHU;$I]Fу{8Z}Pra2\\|,D058-~=aʠ-viPŒW1(piH~[HId4\Ԡ )vQYNģHJ0SԜ@29uIu>,^|NJKfa k")1w+9Yzdy0z(ޤo%(_ϧP qZ6]) JG&A2*#~$& rv& J90cg <'yW|Ldc1baW+dyJ*3*J א @ËVEP D,Cۀ$D'h<|AI3SC!7ȫdMlA`e"&ê$5@?`t$6w3J Sfg, =A}|&}Rtg؝:W^mIrvo>zLd>޴Er#H;B_BcPK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!;VO!drs/slideLayouts/slideLayout1.xmlPKPK!M[Content_Types].xml|N0 EHC-jaj; +,Kq:=ig ,?ϵYD&oDzCwO-gkcg$./XQ{jsԈHt䒦AFP0skfx(壓8?.C(ũ{R(Mb˳7{-IF#{_R'dK0FFjr'"&@_'PK!p8ܾ8 _rels/.rels 0Dnz x%ٶ6 (тqLݾQ(NAU ioo'tGHL m^W16 AJMȅ8a22~`Or[;,lij@搛}YMGBh ]pϔ{J Loc!"rPK!!X!drs/slideLayouts/slideLayout1.xmln0Wwo EI*mpCi'A5Ʋ6yMH]BI|0>4tL j]O?/hCEEy+"82\/~B۽!`g,P;P}J&٦U 5pa`7<'4lh->n6uɾa8bXR4TLf^9JԆ0@,r+"hAּ}b DKɵ\)q߭+$ |mOa 9,눿D v0t0Zމ-w?މ `Ij*/ rRoEBX+z֌x#N(KOV~'1|O"q4$.Y :QM&.j9|k# ZpmșU4~[NcxZC43 1^/ĴU!wTG#r0G2QߐQ|& C2_PK-!M[Content_Types].xmlPK-!p8ܾ8 ._rels/.relsPK-!!X!drs/slideLayouts/slideLayout1.xmlPK< $Slide set templateB[ // /(     H`y ?Rectangle 2"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK![&%قdrs/shapexml.xmlUn8}/@u:1Ip#NgJ")RKR{f(_ZE^?Ȕ8˙sޯ[#ڇL_Jm>g[)BTTYɍu aeFukiVEQu6@^ZXy Wv9fVrESfr|~)U->9<-h0K'Ҙb\RzBߤ!Q1]h{*}FM"SʥEtȲ.=z俽QH}Պ|ɕ8耂+[qU%֙D+7DjQxvf[/ޠfNvGg"Q&=Zթ4DqYwsl\ǺL^]]p)36h0MI_-$Ƥ5 41*MP#%+7 ?TߙQ/R1XKa>Zpj|~D~aHw۷wΰ-5Qx#Sqj]A[=( ĉ샛ת?Oe:%ȉ q7GB¾f̈IGL`x̲+U@7Q 8֞a[rm(PcAU~c ƖʼTWj@fO*ZYLMW4t%;WњKg7v)8Ӕ4n/5PImtš9Vz;~jzr34:!)h5:g7?_PK!'udrs/downrev.xmlDQk0pVFQt q_km.l0f"FRF@u?0z\t+C"!9nI_؞Li 1KC/$-R}-eyPTFq>n߀};ߧ%v>L_N} ' E( | PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-![&%ق)drs/shapexml.xmlPK-!'udrs/downrev.xmlPKP R  \:2___PPT9  P       H } ?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!8 drs/shapexml.xmlUn6}/ Zdm'XeͶq}IT"U%_3|i(A̜s?m-VښL> Pem2F ȔQ*/?v[OL.Bh'/!`W6h px5h6j̉h|-Q_T޴rЛ4X>74>.M;g Eψ;R5Ȕsi"l[dY7dS|8E͖8@]OMS[U/nnW )r4Q l^nr5زu>|V|;ʤC"FZM}"Bp8cjO1jseL8e=7uPN$_**sgSF@Nk&ּOMzK| [n9@)3GֽKv?;rJ oG1Kx'?1]hu^3 ]c6-h\'vV}?6)ha1qbIXIa2C|Ț0LIₜWkϕԘKN#bu%`r,^!mJ!9F q.$kES˕5>)'Ϥ8£v֙S5wA WVTAU -?W;vn=jͻ~g\v4hZc)brFˮG ̙T-"O.Avu1vWR,㻘 & cob'÷/񕋮kY[Ksh?[]s`>[Cf-XH;nUhY_.7i+;:!Frppud\2Á^:jo-agc:~\kTe5牄XO @Sy_ԫO.)YD(E~PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!8 )drs/shapexml.xmlPK-!,drs/downrev.xmlPK  R \:2___PPT9  R      s B ?Rectangle 4  \   H| ?Rectangle 5"c]PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!>Mdrs/shapexml.xmlXn8}_`"=u*Ebl c@KT5EjIʗ|!e'lg̙Tl%+NxC3S1oΆ9/t&2[T\ŰYQըrB}0Xˍ-ǭ}lUV:8Tn}*E%LլZԲ"Ky%N)|xT xQ;ܘt_%b`|3x䕵f"s5mvjxJT l o-#M{޸Fu_Mp& 6Mx7d#FrYAxN_4:>iSR_9+FnXMG펠㴹):ǚa_ p,X. L8+J΂2T:QF$E7ר>:Et@O@>qpTՒ3!.:>JƇc7劮˱Q]BpYwT}Y7߅[3[J~nQHHBFw=療 a!?6 ((#,ZRL]h̅Lejjh{Z|&U4l%(Kreq-׺]C65rZwU׬뱲=i4B Нb/vYEi)":R}l:GФXY8[JKs1lI"(hpx[]4'ٕ~v dQEF/@GTC8Ԓ'&3 !L\U.u2B, ?J}&Ei{f@dx?õiiQM CJa(5'J9RDoBh9ODt}Dz}/CN9{v1!'nل8PK!tdrs/downrev.xmlDj0DnJ#;QB(tY?>ƺZ#]a3a*FRN@]7|@#q,᰿a.d cb|ƜsѯH&vuCz$ɸFeC#|ZzȪS:}|֨r/3 0_^_Ի/[`y8% 􁜀e(PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!>M)drs/shapexml.xmlPK-!tNdrs/downrev.xmlPKR 0 \ RClick to edit Master text styles Second level Third level Fourth level Fifth level!     S)   Nx ?Rectangle 6"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!Mdrs/shapexml.xmlUn7}/ 8\˱ۨ!XZ[q-_3%ARU p.giXijg39z;B•}燳+)BTTYɭͯo'lä"v2b޺V[U7*b_Aۨ"5fp>^U[yWv5ogVjE]fr4F2V5 b,PHcesQ%ҫ5 * aGJFowVewRȔri"n[dYE^3O|&dj+q]u 5T9J >Pfj|>rQ,.N6@v'#Q&=54DYPsj\L^ǜpʌ=75+L!}Ĕm&Q&QyUxT}jZ//n\9~A 4jk @|R?-p=c"o3Rvͽ3,+e xd.EZG|iUy[vϛo{DPOe:%ȉ q'B¾VfĈI'LB`sT-ZTP>hSG6o{V^o)`v:} ϨNɿ-1y Ԁ̞U>Gyd%7r6\  SLYg O=6p*,Ŭb'{Apwv7ppz[O K5ojΡ[^>1H)ˮw@͙<= 'ˤEzb}oJ DA* I#jWo tSg3\Ek/L]Ҹe@%!n҃[ c,MRȆU??nHPK!#M:drs/downrev.xmlDAO1&fLIwM@21*O q;l7lK[a6Mo:\bXjoZi6/7b"1ya3G./TשQ""R_ikˎ,(m2u(&Q+yRO!F8x LcwyG@%bۿf&8К!_l=PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!M)drs/shapexml.xmlPK-!#M:drs/downrev.xmlPK_PR  \:2___PPT9  P       N@u ?Rectangle 7"`ZPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!z1xP drs/shapexml.xmlVM6 x-{F׈Xo3-QkݠoHARuEQ8μyob;i]at»o:I 4o9s^L(e_m5qMo&K7Znl)g/ l#&Y MwASx 7hOH9fBu4Wg(P-:*y NyԵ6 'vcf!rYL%P/JyE9GצE # d/ U?1І#VKO`73˕劮˙QA_B5gќyLY Ы*%#[5YmD%ğa k$Y10m!#I`E iOm!J$pm JJ]#4Tnj |RE``_ S;NJ2{ @㬏R,݆.Fii-i MXeSVy*U2l'0'e=eqh4׬뙲Ouz=sqyzǖ>1Hb,ayO[q޴nGYrljX]eQ_p[W Lcإp ض؂sڬVZ:މ,%)7$4-19ٔXa!xjΨ" Dc !h쥗<i 5i |EFR\”')#1@uB RXAc_Gk?F3q6ZM_ PK!2drs/downrev.xmlLn0V8TO'(KSۅkq@G3FtFɇڱ| .Rxx"1))|v{3B鸉H*014d1 \Kc)m#l$-֜ jAz!Wl9PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!z1xP )drs/shapexml.xmlPK-!2Ldrs/downrev.xmlPKO_ R \:2___PPT9  h*    <  c $ ? 3380___PPT10.I mA PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VJe++2a,/07" ^E2&lQ$Jqdo4$hITI=2פI F"v@+WWF`1Fi 2n !_潽ݫ92&|Z-odtD >^)=9 Zwzގ'YZ 6[ހbFI ]1gVө_,.,_ٴnyL#7i%lOcY ypf \}HU܏qvIGe\¡ WLaW2H7Cᜌv"s,552kfVfULT >,skB'+ \Hn…[4B\$c<"eՍX1g} j&$ݕ% iSncR79YAkg` [xL2f\Jذ?5lA9W%: X64T,՜U0E)`#5hC0cR}גu3mg_Rʧ~<:BC6ܯCQ "͔_Xqۦa8/:ELps̛#V)Q U02hB|m\CbhLhAP]v| rmY:# B,;X=߻,ɂ(G\Y䐰kzoP nI^ dy #Րks|l2R~6 MaZ~cכ*'m֕"+MιڊUҸZ^,k (GEozC~O l /i8AL5mjQ 0,>͙ŋ4vnavl'SA8hć]2%M0pg$hn PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!tH`2theme/theme/theme1.xmlPK-! ѐ'j theme/theme/_rels/themeManager.xml.relsPK]e : 'ʰ!ڰDzԳٱԳٳղ.泾ɱ0ᴿ+%ư(0&7ܪ&*8f;ó6VT-Vʲ԰ʨ)@ŀ< uw}l IvVNLTL3pG|ﴉ`(UoȮy=J2:88Z )9kR /Ju"(\fhnX soiɶGgϤqsJ8 `ֳ'*e$ ީ3/zPK!*8 _rels/.rels 0DnzЃXmlo0of5OIw AN{cݠv=m 838yG 6U} ShLq`L)d=Ҍ\@.;3, ;$e͂): vq}j:zɥ'k茜(f,ƁXA6\m>PK!^Z2" !drs/slideMasters/slideMaster1.xmlKn0z""XYe4e Hd\ MÒ P[+3G?562ckrX$E9{{}IYdV"g;ayIa# l9k8 [ RN:. Ѝ4nV,7Y˲Pn ˷UC3Z#,{%-I;isF&@dq2gԃyR++E5# d[ 0z. c6>XԷ(bm7'Rfѻ04ZJ?ߥgv䐷EUv()Xk^7B&Q7(dܞ iNT6`r6|WMё]2ө>/mBh,^q*!;q{z=x zAm:3Ig"7G%+g(P9R0 FTYl?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 @ (      x@0e0e?Rectangle 2^  \ "The AAN develops these presentation slides as educational tools for neurologists and other health care practitioners. You may download and retain a single copy for your personal use. Please contact guidelines@aan.com to learn about options for sharing this content beyond your personal use.*#K*    K   7rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 P(  )   x '0e0e?Rectangle 2$  \ ]Presentation Objectives      x$0e0e?Rectangle 3 p  \ N    rB  J>?Line 5rB  J>?Line 6    Hx"?Rectangle 7 ` To review the evidence on care of the patient with amyotrophic lateral sclerosis (ALS) Drug, nutritional, and respiratory therapies Multidisciplinary care, symptom management, and cognitive/behavioral impairment To present evidence-based recommendations^W  -*  <$ "*    33y___PPT10Y+D=' = @B +"7 `(     x&0e0e?Rectangle 2$  \ NOverview        x#0e0e?Rectangle 3 p  \ N    rB  J>?Line 4rB  J>?Line 5  Z  H&?Rectangle 8 ` Background Gaps in care AAN guideline process Analysis of evidence, conclusions, recommendations Recommendations for future research     33y___PPT10Y+D=' = @B +"7 p(     x $0e0e?Rectangle 2$  \ P Background        x'0e0e?Rectangle 3 p  \ N    rB  J>?Line 4rB  J>?Line 5  ,  H@%?Rectangle 60 `S In 1999, the ɫ (AAN) published an evidence-based practice parameter for managing patients with amyotrophic lateral sclerosis (ALS).1 Since that publication, there have been some important new studies, including a randomized controlled trial of noninvasive ventilation (NIV) in ALS.2 Although only one drug, riluzole, has shown modest benefit and received US Food and Drug Administration (FDA) approval, there have been advances in symptomatic treatment for patients with this disease. This revision updates the riluzole practice advisory and addresses other management issues for care of patients with ALS.   "  "*"&"*.C"&*"*""   33y___PPT10Y+D=' = @B +"7 (     x'0e0e?Rectangle 2$  \ R Gaps in Care        x%0e0e?Rectangle 3 p  \ N    rB  J>?Line 4rB  J>?Line 5  F  H(?Rectangle 60 `S nAs of the publication of this guideline update, only one drug, riluzole, has received FDA approval. The evidence for recent advances in symptomatic treatment for patients with ALS was not systematically examined before this parameter update. Consensus-based general principles of ALS management have been developed to guide clinicians in managing patients with ALS. o o"o   33y___PPT10Y+D=' = @B +"8 7 OG /(   '   x@+0e0e?Rectangle 2@  \ [AAN Guideline Process      x`)0e0e?Rectangle 3 p  \ N    rB  J>?Line 4rB  J>?Line 5    H,?Rectangle 6P0s :Clinical Question Evidence Conclusions Recommendations           :  ;   2   ~*1?AutoShape 7 p  \ "   2   ~ *1?AutoShape 8 p  \ "   2   ~+1?AutoShape 9 p  \ "   33y___PPT10Y+D=' = @B +" 7   $ (  $$ $  x,0e0e?Rectangle 2 `  \ XClinical Questions    $  x@(0e0e?Rectangle 3 p  \ N    rB $ J>?Line 4rB $ J>?Line 5  ) $ H`,?Rectangle 6"PK![Content_Types].xml|N0 HC+jS8 @:Q۸ ??\o<7p]V޷O(I'6E=, ){Ō4>I)q7UuDހǏ)}nL"Mᴸ&g0eSA)΄2';2 WYu7{ɯΒzŘqFrj9K*(]mOlPK!Z,[ _rels/.relslj0 ``t_Pƈ[>,dgzjǎ?I'f#®Pb-\/Ƿ0Z]nLnp__3.iJV KQBiDžrL,Vʌ/7р4`ANar+m;E/'3U Aںv83/PK!-Ydrs/downrev.xmlDJ@@EBn$AT+4 k=ox3oM+zqV$AtDh5Β3X-//j7-EKlHQAcJʚ 2;8o0+=,7&ɽ4XPcGcm ^3ΞӺxQj|ziHWknf!;Fo1D 8s\PK-![Content_Types].xmlPK-!Z,[ _rels/.relsPK-!-Ydrs/downrev.xmlPK00S,$D \ 3The first step in developing guidelines is to clearly formulate questions to be answered. Questions address areas of controversy, confusion, or variation in practice. Questions must be answerable with data from the literature. Answering the question must have the potential to improve care/patient outcomes.4 4"4   33___PPT10b+DDF' = @B D' = @BA?%,( < +O%,( < +D' = @B%(D#' = @B%(D' =4BBB@B%(D' =1:Bvisible*o3>+#.<*$Z%(D' =+4 8?dCB1+#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*$ZD' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*$ZD' = @B%(D#' = @B%(D' =4BBB@B%(D' =1:Bvisible*o3>+#.<*$Z%(D' =+4 8?dCB1+#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*$ZD' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*$ZD' = @B%(D#' = @B%(D' =4BBB@B%(D' =1:Bvisible*o3>+#.<*$%(D' =+4 8?dCB1+#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*$D' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*$D' = @B%(D#' = @B%(D' =4BBB@B%(D' =1:Bvisible*o3>+#.<*$4%(D' =+4 8?dCB1+#ppt_w/2BCB#ppt_xB*Y3>B ppt_x<*$4D' =+4 8?\CB#ppt_yBCB#ppt_yB*Y3>B ppt_y<*$4+" 7   ( (  ( (  x@.0e0e?Rectangle 3 p`  \ N    rB ( J>?Line 4rB ( J>?Line 5   ( N`/?Rectangle 7@ Literature Search/Review "( &$  v }  (C (Group 9"} g ( N 11?Text Box 10  xRelevant(  ""    ( N11?Text Box 11} xComplete(  ""   b ( h1ff1?AutoShape 12By  \ "  x i  (C *Group 13"pj  ( N-1?Text Box 14nD vSearch( ""    ( N/1?Text Box 15n@  Review abstracts( ""    ( N`01?Text Box 16i   Review full text( ""    ( N01?Text Box 17i /  Select articles( ""  R ( h.ff1?AutoShape 18   \ "     ( N0?Rectangle 70 $Rigorous, Comprehensive, Transparent"%( %&%   33y___PPT10Y+D=' = @B +" 7 ,(  ,1 ,  x30e0e?Rectangle 2  `  \ eAAN Classification of Evidence      ,  x@20e0e?Rectangle 3 p  \ N    rB , J>?Line 4rB , J>?Line 5  8 , H`3?Rectangle 7  `C All studies rated Class I, II, III, or IV Five different classification systems: Therapeutic Randomization, control, blinding Diagnostic Comparison to gold standard Prognostic Screening Causation Q Z  Z! Z  Z Z Z ZQ  !         33y___PPT10Y+D=' = @B +" p!7 0(  0 0  x20e0e?Rectangle 3 p  \ N    rB 0 J>?Line 4rB 0 J>?Line 5  / 0  x 40e0e?Rectangle 7  `  \ cAAN Level of Recommendations     0 H3?Rectangle 8"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!W&drs/shapexml.xmlZn6;Y;&*dѴwas@KTZ"v,}>I!)"qQwAFp8_VUɖ4V ?~LTgzH绛s+T&Jdײ.}=jj zM(+ѼӵT˵ūyF6RYa1QUY zbJ?-'x99%*{+SpPJv{я`dÿ',qG!ORd zE}cvWWUnrEttU‡?BlYO0#,E`pvR` Og'} ֦?KfJVJrXJ7MMQo[dJ=%Rq {媰Ұ >]^d?̡XQK,TNhW:[jgx S j;kX>~j`e0ㄟ dexM8rYg2xxZ Q> e23<`c)XrCf`B7og' bcRMktZ :kDmPAøK\g ;[|,il>odbX[o\V̼Èds |LJ /ҿ^X¥:0;IwA3oxÛ/Gۊ}h)NH3 U  Dn3X.:5nyK(ZAcJ!1+:+iXn[$OC;\X|VPl}#w);7noƗg\~2-d9!We r PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!W&)drs/shapexml.xmlPK-!Adrs/downrev.xmlPK `n$D \:2___PPT9  ZA = Established as effective, ineffective or harmful (or established as useful/predictive or not useful/predictive) for the given condition in the specified population. B = Probably effective, ineffective or harmful (or probably useful/predictive or not useful/predictive) for the given condition in the specified population. C = Possibly effective, ineffective or harmful (or possibly useful/predictive or not useful/predictive) for the given condition in the specified population. U = Data inadequate or conflicting; given current knowledge, treatment (test, predictor) is unproven. Note that recommendations can be positive or negative. I0 Z90 Z0 Z  9  33YQ___PPT101+4`D' = @B D' = @BA?%,( < +O%,( < +D' = @B%(D' = @B%(D1' =4BBB@B%(D' =1:Bvisible*o3>+#.<*0%(D' =-m6Bbox(in)*<3<*0D' = @B%(D' = @B%(D1' =4BBB@B%(D' =1:Bvisible*o3>+#.<*0F%(D' =-m6Bbox(in)*<3<*0FD' = @B%(D' = @B%(D1' =4BBB@B%(D' =1:Bvisible*o3>+#.<*0F%(D' =-m6Bbox(in)*<3<*0FD' = @B%(D' = @B%(D1' =4BBB@B%(D' =1:Bvisible*o3>+#.<*0I%(D' =-m6Bbox(in)*<3<*0ID' = @B%(D' = @B%(D1' =4BBB@B%(D' =1:Bvisible*o3>+#.<*0J%(D' =-m6Bbox(in)*<3<*0J+" 7 4(  4rB 4 J>?Line 48 4  x90e0e?Rectangle 2@  \ l$Translating Class to Recommendations% %(%  & 4  x70e0e?Rectangle 3P `s \ ZA = Requires at least two consistent Class I studies.* B = Requires at least one Class I study or two consistent Class II studies. C = Requires at least one Class II study or two consistent Class III studies. U = Studies not meeting criteria for Class I through Class III.    rB 4 J>?Line 5   33y___PPT10Y+D=' = @B +"7 8{(  8rB 8 J>?Line 4? 8  x70e0e?Rectangle 2@  \ s+Translating Class to Recommendations, cont., ,(,   8  x40e0e?Rectangle 3P `s \ <* In exceptional cases, one convincing Class I study may suffice for an  A recommendation if 1) all criteria are met, 2) the magnitude of effect is large (relative rate improved outcome >5 and the lower limit of the confidence interval is >2).     rB 8 J>?Line 5   33y___PPT10Y+D=' = @B +"7 <(  <6 <  x60e0e?Rectangle 2@  \ j"Applying This Process to the Issue# #(#  X <  x@80e0e?Rectangle 3 ` \ 4 We will now turn our attention to the guidelines.& 2 55  rB < J>?Line 4rB < J>?Line 5   33y___PPT10Y+D=' = @B +"7 @(  @$ @  x80e0e?Rectangle 2@  \ XClinical Questions    @  x@50e0e?Rectangle 3 `~ \ZR___PPT94, s1. Does riluzole prolong survival or slow disease progression in ALS? 2. Does lithium carbonate prolong survival or slow disease progression in ALS? What is the effect of enteral nutrition administered via percutaneous endoscopic gastrostomy (PEG) on weight stability? When is PEG indicated in ALS? What is the efficacy of nutritional support via PEG in prolonging survival? What is the effect of enteral nutrition delivered via PEG on quality of life (QOL)? b Z8 " Z Z7  rB @ J>?Line 4rB @ J>?Line 5   33y___PPT10Y+D=' = @B +"7  D(  D+ D  x90e0e?Rectangle 2@  \ _Clinical Questions, cont.   T D  x40e0e?Rectangle 3 `r \NF___PPT9(  2What is the efficacy of vitamin and nutritional supplements on prolonging survival or QOL? What are the optimal pulmonary tests to detect respiratory insufficiency? Does NIV improve respiratory function or increase survival? How do invasive ventilation and NIV affect QOL? What factors influence acceptance of invasive ventilation and NIV? What is the efficacy of targeted respiratory interventions for clearing secretions? F " Z Z  rB D J>?Line 4rB D J>?Line 5   33y___PPT10Y+D=' = @B +"7 0H(  H+ H  x:0e0e?Rectangle 2@  \ _Clinical Questions, cont.   2 H  x@;0e0e?Rectangle 3 `z \VN___PPT90(   How should a physician tell patients that they have ALS? Does multidisciplinary management improve outcomes? What are the most effective treatments for sialorrhea? What pharmacologic measures reduce pseudobulbar affect? What pharmacologic interventions reduce fatigue? What interventions reduce cramps? What interventions reduce spasticity? What pharmacologic interventions reduce depression? > " Z " Z  rB H J>?Line 4rB H J>?Line 5   33y___PPT10Y+D=' = @B +"7 @L(  L+ L  x:0e0e?Rectangle 2@  \ _Clinical Questions, cont.    L  x<0e0e?Rectangle 3 `r \NF___PPT9(  ]What pharmacologic interventions reduce anxiety? What pharmacologic interventions reduce insomnia? What is the prevalence and natural history of cognitive and behavioral impairment in ALS? How is cognitive or behavioral impairment in ALS diagnosed? What is the effect of cognitive or behavioral impairment on management of patients with ALS? What treatments are effective for cognitive or behavioral impairment in ALS? What treatments for dysarthria optimize communication in ALS? : " Z Z  rB L J>?Line 4rB L J>?Line 5   33y___PPT10Y+D=' = @B +"7 ,$PP (  P+ P  x;0e0e?Rectangle 2@  \ _Clinical Questions, cont.    P  x<0e0e?Rectangle 3 `r \NF___PPT9(  What treatments reduce pain and dyspnea in the terminal phase of ALS? Do hospice care, spiritual interventions, or advance directives improve quality of life in the terminal phase of ALS? What is the optimal method of withdrawing both NIV and invasive ventilation in ALS? : " Z Z  rB P J>?Line 4rB P J>?Line 5   33y___PPT10Y+D=' = @B +"7 `T(  T T  x`<0e0e?Rectangle 2@  \ MMethods   L T  x=0e0e?Rectangle 3 ` \ OVID, MEDLINE EMBASE, CINAHL, Science Citation Index, BIOETHICSLINE, International Pharmaceutical Abstracts (IPAB), OVID Current contents, Medline-ProQuest, EIFL, and INVEST 1998 through September 2007 Relevant, fully published, peer-reviewed articlesR ZN Z2  rB T J>?Line 4rB T J>?Line 5   33y___PPT10Y+D=' = @B +"7 pX(  X  X  x =0e0e?Rectangle 2@  \ TMethods, cont.     X  x@>0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!5I%drs/shapexml.xmln6 Ys0,i  #΢-ѱTIڱsw$,(Mv|A0$C~MGkMdz,2Qi&cEr\I0_cSF,͸rd) nީRH-.ERwJ-[tT~{)x&Y9K>:ҘшEV$P>рu¡D%&(?ETGpOHo5Czĥq)xj(v.2ZUeP~alxv|?z^ c5\9S  &J?QsZ(^b0g3m]b8:#%f\*w2A1,kj'(Y m~ຌ(Jbc?ْ XjS%ؙb_ht^^ڊkSp=ؑuFװ22b쨒=YϞ٭#D^g兒UsCjd(FZXӕLЉ7vN'LL9v[)p%q'&j˅=\(s}qFfO FK*%b/^|l/>mn,> *By3c1 l9,{ۻp3.=Mf.Ƣ1O EY6<{߹$Y?hseSLۭ^炻I\R(M)Ǩ >R OWG)?_p[[ۇ<9jZZZ^3yV{8έ8O B2oko&NFfsb#8cJ]f_7g{y[w7 ÈgfN-rw-~4md؁9}VcmP%d:_o=[ҿW QS^PK!+drs/downrev.xmlDN0DHHܨCTVT 4=mM:68q47zhzq"; ' jydeRp! m\i! TІ0R%~b3btnz&T8>8KKhtee>{Uf|~h cζz+QZAyⰺ]K􁜂m)PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!5I%)drs/shapexml.xmlPK-!+drs/downrev.xmlPK ` \ TSearch terms Combined the words ALS, Lou Gehrig's disease, and motor neuron disease with the following words using AND: respiratory, respiratory failure, respiratory insufficiency nutrition, enteral nutrition, malnutrition, weight loss, gastrostomy clinical trials mechanical insufflation-exsufflation, high frequency chest wall oscillation, Vest, Bipap, tracheostomy ventilation, dysphagia, mechanical ventilation, noninvasive ventilation, hypoventilation, bronchial secretions, sleep-disordered breathing, breath stacking sialorrhea, pseudobulbar palsy, pseudobulbar affect, emotional lability D  Zk Z k UrB X J>?Line 4rB X J>?Line 5   33y___PPT10Y+D=' = @B +"!7 80\(  \  \  xc 0e0e?Rectangle 2@  \ TMethods, cont.    \  x`c 0e0e?Rectangle 3 ` \ Search terms, cont. palliative care, diagnosis, telling the diagnosis, breaking the news, advance directives, hospice botulinum toxin A, botulinum toxin B, parotid irradiation, anticholinergic drugs, amitriptyline, glycopyrrolate, benztropine, transdermal hyoscyamine, atropine, trihexyphenidyl hydrochloride, propranolol, metoprolol, dextromethorphan, quinidine, opioids, opiates, lorazepam oxygen, dyspnea, pain, anxiety, sleep, depression, cramps, spasticity, insomnia, deep venous thrombosis, communication devices, fatigue, constipation multidisciplinary clinic, specialty clinic cognitive impairment, dementia, frontotemporal dementia, executive dysfunction , Z  rB \ J>?Line 4rB \ J>?Line 5   33y___PPT10Y+D=' = @B +"7 `(  `  `  x c 0e0e?Rectangle 2@  \ TMethods, cont.   ` `  x 70e0e?Rectangle 3 ` \ DAll panelists reviewed each article for inclusion. Risk of bias was determined using the classification of evidence for each study (Classes I IV). Strength of practice recommendations were linked directly to levels of evidence (Levels A, B, C, and U). Conflicts of interest were disclosed. # "#  rB ` J>?Line 4rB ` J>?Line 5   33y___PPT10Y+D=' = @B +"47 KCd+(  d# d  x>0e0e?Rectangle 2@  \ WLiterature Review    d  x`?0e0e?Rectangle 3 ` \ :Inclusion criteria: Relevant to the clinical questions Limited to human subjects Randomized controlled trials, cohort studies, case control studies, case series, meta-analyses, and review papers Exclusion criteria: Articles related to postpolio conditions, cancer, or non-ALS disease Articles not peer-reviewed  ` `  ;  rB d J>?Line 4rB d J>?Line 5   33y___PPT10Y+D=' = @B +"} 7 ht(  hrB h J>?Line 4S h  x?0e0e?Rectangle 2  \ ;AAN Classification of Evidence for Therapeutic Intervention< <(<   h  x`60e0e?Rectangle 3 ` \ !Class I: A randomized, controlled clinical trial of the intervention of interest with masked or objective outcome assessment, in a representative population. Relevant baseline characteristics are presented and substantially equivalent among treatment groups or there is appropriate statistical adjustment for differences. The following are also required: a. concealed allocation, b. primary outcome(s) clearly defined, c. exclusion/inclusion criteria clearly defined, d. adequate accounting for drop-outs (with at least 80% of enrolled subjects completing the study) and cross-overs with numbers sufficiently low to have minimal potential for bias. e. For non inferiority or equivalence trials claiming to prove efficacy for one or both drugs, the following are also required**: 1. The authors explicitly state the clinically meaningful difference to be excluded by defining the threshold for equivalence or non-inferiority. 2. The standard treatment used in the study is substantially similar to that used in previous studies establishing efficacy of the standard treatment. (e.g. for a drug, the mode of administration, dose and dosage adjustments are similar to those previously shown to be effective). 8 Z  rB h J>?Line 5   33y___PPT10Y+D=' = @B +" 7   l (  lrB l J>?Line 4Z l  xc 0e0e?Rectangle 2  \ BAAN Classification of Evidence for Therapeutic Intervention, cont.C C(C    l  xc 0e0e?Rectangle 3 ` \ R  3. The inclusion and exclusion criteria for patient selection and the outcomes of patients on the standard treatment are comparable to those of previous studies establishing efficacy of the standard treatment. 4. The interpretation of the results of the study is based upon a per protocol analysis that takes into account dropouts or crossovers. Class II: A randomized controlled clinical trial of the intervention of interest in a representative population with masked or objective outcome assessment that lacks one criteria a e above or a prospective matched cohort study with masked or objective outcome assessment in a representative population that meets b e above. Relevant baseline characteristics are presented and substantially equivalent among treatment groups or there is appropriate statistical adjustment for differences. Class III: All other controlled trials (including well-defined natural history controls or patients serving as own controls) in a representative population, where outcome is independently assessed, or independently derived by objective outcome measurement.*** \ Z Z\  N  rB l J>?Line 5   33y___PPT10Y+D=' = @B +"7  p(  prB p J>?Line 4Z p  x`c 0e0e?Rectangle 2  \ BAAN Classification of Evidence for Therapeutic Intervention, cont.C C(C  ^ p  xc 0e0e?Rectangle 3 ` \ Class IV: Studies not meeting Class I, II or III criteria including consensus or expert opinion. **Note that numbers 1 3 in Class Ie are required for Class II in equivalence trials. If any one of the three is missing, the class is automatically downgraded to Class III. ***Objective outcome measurement: an outcome measure that is unlikely to be affected by an observer s (patient, treating physician, investigator) expectation or bias (e.g., blood tests, administrative outcome data). b Z Zb    rB p J>?Line 5   33y___PPT10Y+D=' = @B +"3 7 J B t* (  trB t J>?Line 4N t  xc 0e0e?Rectangle 2  \ 6AAN Classification of Evidence for Diagnostic Accuracy7 7(7   t  x c 0e0e?Rectangle 3 ` \ tClass I: A cohort study with prospective data collection of a broad spectrum of persons with the suspected condition, using an acceptable reference standard for case definition. The diagnostic test is objective or performed and interpreted without knowledge of the patient s clinical status. Study results allow calculation of measures of diagnostic accuracy. Class II: A case control study of a broad spectrum of persons with the condition established by an acceptable reference standard compared to a broad spectrum of controls or a cohort study where a broad spectrum of persons with the suspected condition where the data was collected retrospectively. The diagnostic test is objective or performed and interpreted without knowledge of disease status. Study results allow calculation of measures of diagnostic accuracy. 6; Zi ;  rB t J>?Line 5   33y___PPT10Y+D=' = @B +"7 x(  xrB x J>?Line 4U x  xc 0e0e?Rectangle 2  \ =AAN Classification of Evidence for Diagnostic Accuracy, cont.> >(>   x  xc 0e0e?Rectangle 3 ` \ KClass III: A case control study or cohort study where either persons with the condition or controls are of a narrow spectrum. The condition is established by an acceptable reference standard. The reference standard and diagnostic test are objective or performed and interpreted by different observers. Study results allow calculation of measures of diagnostic accuracy. Class IV: Studies not meeting Class I, II or III criteria including consensus, expert opinion or a case report. 6 Zr p  rB x J>?Line 5   33y___PPT10Y+D=' = @B +"7 |(  |& |  xc 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    |  xc 0e0e?Rectangle 3` \ R Question 1: Does riluzole prolong survival or slow disease progression in ALS? 8S  !D!S   | N`c ?Rectangle 4 i  ( $  rB | J>?Line 5rB | J>?Line 6   33y___PPT10Y+D=' = @B +"7 ( (  /   x=0e0e?Rectangle 2@  \ cConclusion/Recommendation (     x@c 0e0e?Rectangle 3 ` \  Conclusion: Riluzole is safe and effective for slowing disease progression to a modest degree in ALS (four Class I studies). Recommendation: Riluzole should be offered to slow disease progression in patients with ALS (Level A).  ZqW Z qM  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7  (  &   x c 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x@c 0e0e?Rectangle 3` \ [ Question 2: Does lithium carbonate prolong survival or slow disease progression in ALS? 8\  !M!\    N@c ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"#7 :20(  /   xc 0e0e?Rectangle 2@  \ cConclusion/Recommendation (     xc 0e0e?Rectangle 3 ` \  Conclusion: There are inadequate data on the effectiveness of lithium carbonate (one Class III study). Recommendation: There are insufficient data at this time to support or refute treatment with lithium carbonate in patients with ALS (Level U).  Z[ Z [u  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 @(  &   x c 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x c 0e0e?Rectangle 3` \ b Question 3: What is the effect of enteral nutrition administered via PEG on weight stability? 8c  !S!c    N c ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"b7 yqPY(  /   x c 0e0e?Rectangle 2@  \ cConclusion/Recommendation (     x@ c 0e0e?Rectangle 3 ` \ *: Conclusion: Enteral nutrition administered via PEG is probably effective in stabilizing body weight/body mass index (two Class II, seven Class III studies). Recommendation: In patients with ALS with impaired oral food intake, enteral nutrition via PEG should be considered to stabilize body weight (Level B).  Z Z ~;  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 `(  &   x c 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   c   x` c 0e0e?Rectangle 3` \ - Question 4: When is PEG indicated in ALS? 8.  !!.    Nc ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 p(  /   x c 0e0e?Rectangle 2@  \ cConclusion/Recommendation (     x c 0e0e?Rectangle 3 ` \  Conclusion: There are no studies of ALS-specific indications for the timing of PEG insertion, although patients with dysphagia will possibly be exposed to less risk if PEG is placed when forced vital capacity (FVC) is above 50% of predicted (one Class III study).3 Recommendation: There are insufficient data to support or refute specific timing of PEG insertion in patients with ALS (Level U).3  Zs Z  h   rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   x`c 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x c 0e0e?Rectangle 3` \ [ Question 5: What is the efficacy of nutritional support via PEG in prolonging survival? 8\  !M!\    N@| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 w(  /   x c 0e0e?Rectangle 2@  \ cConclusion/Recommendation (     x@c 0e0e?Rectangle 3 ` \ HX Conclusion: Studies using appropriate controls or multivariate analysis demonstrated that PEG is probably effective in prolonging survival in ALS, although insufficient data exist to quantitate the survival advantage (two Class II studies). Recommendation: PEG should be considered for prolonging survival in patients with ALS (Level B).  ZQ Z GY  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   xA| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x@| 0e0e?Rectangle 3` \ Q Question 6: What is the effect of enteral nutrition delivered via PEG on QOL? 8R  !C!R    NB| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 %(  /   xc 0e0e?Rectangle 2@  \ cConclusion/Recommendation (     x`@| 0e0e?Rectangle 3 ` \  Conclusion: No evidence exists regarding the effect of enteral nutrition on quality of life. Recommendation: There are insufficient data to support or refute PEG for improving quality of life in patients with ALS (Level U).  ZRs Z Ri  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7  (  &   x`C| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xA| 0e0e?Rectangle 3` \ j Question 7: What is the efficacy of vitamin and nutritional supplements on prolonging survival or QOL? 8k  !\!k    ND| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 (     x A| 0e0e?Rectangle 2@  \ S Conclusions  (       x@B| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!.m# drs/shapexml.xmlYQo6~@uHN$@F`)k('O%%;E dU. ح#X{Pu CNCԨ.6z'KcvFȓy'e+y7(FlnEorT7/1Bq"V̼\(E@$y[L:R|"# a?2 CP=QS^j81C%EKe,}9 Ru7E1w$ѵLn/2)F8StWeemZ =tF ogxlSJHuXU-IMva/:,Y xƐ3bjeh1Dxr2Uq[_;Ku^bc;8([Qg*T1I@UU͂QW.7%Q}f1n>R4notfxɯԝ/sᇢ=a+kC6mhR61cI!ʪ1C C"~J\n/~ldj5M'\)ؖqFU 5zFHh8UJQߐ#lw @M@J&B A6q7NνKqC('C Y܄7^~ /f=%f?%櫇M Ae-\+A< Phr/PK!bdrs/downrev.xmlDMO0DHkQ-6ԭP>.Hizᶍ!^GӦz,pb5VXx 6\+ؖ5Ig ̵;rAMEpQAcK,SwbLR{<&m$nE6U3-~sfi|QˋD! Lg9i.0D _M ?PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!.m# )drs/shapexml.xmlPK-!bdrs/downrev.xmlPK ` \  Conclusions: Creatine, in doses of 5-10g daily, is established as ineffective in slowing the rate of progression or in improving survival in ALS (two Class I studies). Vitamin E 5,000 mg/d plus riluzole is probably ineffective in improving survival or functional outcomes (one Class I study). Vitamin E (1,000 mg/d plus riluzole) was marginally effective in slowing the progression of ALS from milder to more severe ALS health states using a single measure but is ineffective using multiple other measures (one Class I study). ~ Z Z  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"67 ME-(  #   x G| 0e0e?Rectangle 2@  \ WRecommendations (      xF| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!b& drs/shapexml.xmlYn6}/ Zd8&6"/i gǂXD$y?%=CJ5mvtۢ҃ː9FVyƖTks&UTG9g L+.-+/">wZ6\w }3mrP5H+ Yno"U|rR ذ4IǙ91$;J. cㅭLbvS[cM=c5yi~KXjƺ-`K1gn]@˩Nʯ"gi5.c^-7VW9}|+00ȧ;jlPJUWQ$Dv8KNL' v1xJ1RWf3ܥ2QnMxT1i{,3BԳE<[ RMw@ #q%gȍ(J\ܡl=%i9ʣ<-'5܀B`z"> (D?\pKuqJs(̦/Hq%L@@*=%)*)U4),}*aDvolr%a&4ݕN,8th:Kj9JVR`])9jtʑ+isL\e q0%q `%&S7D~F6%Ƿa1n_)0o9݊spKa ?TVD)P!Ȅ '05=;`CvOݛۄӡsY/YzP=*pCn?Q?sc`?,c\<R]{/pY&P`8Fd,@P&߰̆eD_8I[Con J_iT2\F%4*ӨM4Bex=>lc9֪3 kOY ~%o]ퟝH~"i5?/- im1PK!66drs/downrev.xmlDn0Dk+VHHAD m%#@=fFouˮ伲Fh#SYL-Pn|@#b>xa.t݇E9 hBr}ՐF?؝bt5o[>N רL|hUCyj||KtIî/.k!+@}g/j+/Q~?:% 􁜀m)PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!b& )drs/shapexml.xmlPK-!66drs/downrev.xmlPK ` \ 1SRecommendations: Creatine, in doses of 5-10g daily, should not be given as treatment for ALS because it is not effective in slowing disease progression (Level A). High-dose vitamin E should not be considered as treatment for ALS (Level B), while the equivocal evidence regarding low-dose vitamin E permits no recommendation (Level U). @ ZGX TrB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   x@E| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xG| 0e0e?Rectangle 3` \ Y Question 8: What are the optimal pulmonary tests to detect respiratory insufficiency? 8Z  !K!Z    NI| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"/7 F>&(     xD| 0e0e?Rectangle 2@  \ S Conclusions  (       x@H| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!Iu} kH"drs/shapexml.xmlZn6;Y'^gQIゖXD$9}~C!E p8 I:JjwI$Utw}pʙuB%"JF|#-xg _8Wz=/d.;]H6p^a ?=rc?oIx `Jl0#M^R$^cܞ7UTX0)`L'ᇓŜd=Ĉ4`ׯ ꀃ6O=YߗHβ_&3< i+>*2ke~3P1FqW5u^7V"&AKa[`TD'v7zb5PmjdM~%$VWŒi;jl"U z* #29S݅>Rեy(ϵrLXrFBkwT1 `gC~+Q az;A/ת#$dLA.PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!Iu} kH")drs/shapexml.xmlPK-!cCdrs/downrev.xmlPK ` \ $n Conclusions: Nocturnal oximetry and maximal inspiratory pressure (MIP) are possibly more effective in detecting early respiratory insufficiency than erect FVC (two Class III studies). Supine FVC is possibly more effective than erect FVC in detecting diaphragm weakness and correlates better with symptoms of nocturnal hypoventilation (two Class III studies).  Z\ Z [ orB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7   v (  &   xJ| 0e0e?Rectangle 2@  \ ZConclusions, cont. (      xI| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!a_#drs/shapexml.xmlZn6}/ ZdxMlDY$0#΢-ѱjTIqKz$(@ I2BjI$Ur}w̙uB%"JF^ZN-:++">uZ6\ mmrP5H+YTSRQ14T/C$;]Δ1알am&GZɅ.v t<+csI `*SMR$^cܖ7UT2w_ʱN9_FvU \-'yz"z~* m83ͅe+L{i+ã6*feޢy_gbh,5u^7P"&AKa^!LNr.h* b`.RY7r}KH0 FVW~raB}+BJxK={n]g\aEB)<ܙ2HרU3UA!O"Ǝ-:^8MQc% mʖ*!j^zCUL%"qb=r彀P4[L:R}!"1a?< CP2 ȗ8I 3h╢(7_%ȳbo']?k$3EO/,+,M襯Pl)p!u)9 ԕjޜԬ~931%W{#EO)BCl7bZ&Ny"UD r"$1FmJnىM*JUW;W5a@aoǙN8S|+3{$^!̾wI뉻<.Q'J[v 2n|5r'^SgyPS|m!G4Xxp1yQ^ 7 N)~X<0ſ^ [+Z(ѝ@[y3zޜzF9y䩨f)_sgW+W&mr(hABxKöw7PQ#Ƣ.i^tn=_Za@PK!/zV@drs/downrev.xmlDN0EH5HӇ6ԭ_z Ɠpbry l)PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!a_#)drs/shapexml.xmlPK-!/zV@drs/downrev.xmlPK ` \ z Conclusions, cont.: Sniff transdiaphragmatic pressure (Pdi) and sniff nasal pressure (SNP) are possibly effective in detecting hypercapnia and nocturnal hypoxemia (two Class III studies).  Z Z rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"[7 rj R(  #   x D| 0e0e?Rectangle 2@  \ WRecommendations (      x@K| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!8)drs/shapexml.xmlZN8}_i)2@E:$vWPEM\%[ZKN11Dk\s\|ZYpS)"a.b&/v(цeR?tRuAY~љ1ELhJ3k. 3(:ݏ0Xr1R$M";;D^JdN)01.aQ&Q+lAUa){S0?UJ8K}y;NJWU.ŌU-'2YQ(h{;x=>(ya ^ƚb ='oG=/_ jT)ULqJsUz]TTel\f&bQC/;yP ڵJLщ/ͥX[ 6e]`ɴ!$l:əFF>Qr d R*ltn]% ^4ݠs6g֕RSe´5FEIvEުx`V]{ $g|PYb<\:gzPuK+'běȕs ?yԃUGcPAa2qҋ#*0e,!%\7Rv⑰47Wg%;6RRN]9IYyƙj {"2-49p1KO)0YSO P0e9SC_rʃhKnK"E[=lMm&ԤDH[Du pN5>gȈ3y4,Uӕ-௮7kHAه=S*W`;Ow[/!#۶ܭm;eH}qA*{=lx*#RYՌY J7oF[0zb{QmQ,DݧM=UƦFr/bzvBt|FطZ!?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 0(  &   xM| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xG| 0e0e?Rectangle 3` \ K Question 9: Does NIV improve respiratory function or increase survival? 8L  !=!L    NJ| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 @(  0   xL| 0e0e?Rectangle 2@  \ dConclusions/Recommendation (      xE| 0e0e?Rectangle 3"  PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!$drs/shapexml.xmlZN#7wbٰaH"VDΌCxUߡo'wL(,[>c;'׹VL|gPN3u/7{,KDeO"BgeGE^& sABmMHs+B90Q.{Ogb(Cj51Q`"sL{-q'EJЅCNm) 0XaKH r93cBR5y+YD%YE H9# QxX `V5Ÿ9z\~)PYUޒ)~;x3 )W{ґHCCb[ `wY"W)3Sq[Q%Jvbm oErr# UQLJGWE}(&*)L+xD7.`5e)USۨ4u6ĦQ7Ȫǖr;? :?.Yx'aD>;u~R`U]#yR9SeƁTRwrED;AXV]b~]Eg6jp;jbiW7|U` Yˆ^~Bç }Zx[zsEw6_wCuֳtlpxPSf{t9jP@DW:ڥu:L53`J'p^wգ>T ~ 0(PK!Mdrs/downrev.xmlDN1E&CLI0F !Dðq>´ކ.o͹9Eo[vwK㔀mz ;p K/&)!.(@ԕF8}r ˀ - h\~ћ9Y;3OUv>߅x|藯V˿ϓ~}#+m)/PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!$)drs/shapexml.xmlPK-!Mdrs/downrev.xmlPK ` \ Dj Conclusions: NIV is probably effective in prolonging survival (one Class I, three Class III studies). NIV is probably effective in slowing the rate of FVC decline (one Class I, one Class III study). Recommendation: NIV should be considered to treat respiratory insufficiency in ALS, both to lengthen survival and to slow the rate of FVC decline (Level B).  Z  krB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 P(  &   xO| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   v   xM| 0e0e?Rectangle 3` \ @ Question 10: How do invasive ventilation and NIV affect QOL? 8A !1!A    NP| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"D7 [S`;(     xN| 0e0e?Rectangle 2@  \ S Conclusions  (       x`O| 0e0e?Rectangle 3"  PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!:z)drs/shapexml.xmlZN#7w|[lXHdH"VDΌC'}>IcO.l t'ƞ4a iXLPG 닽cr+T$de?$dOzVNe*w: cmRa4\*+,6JV{C+},lh^.Qw)b+DU)| t8 fS `JlpϧMRD9ucߖcUU%2{˱9_vb'Ys.0"zq@8hٝ8U\Ya$m]sxFìWG<=׉CFr-u ;P,$B:Kfr{MQ^Td *kzh$#{o .ۮ|Ra>Ύ֕!Y%t*|-+,k1=" ح#@Cy=uS"'jT1)\ă^вyW dXbtb7i%AW特^:CUI%<#b%/zY)(ic-p>]9䰳<=*=r5f@ *RUt)RI qM<׹zQl콫=Op+ljR8IJh:#t 8yإ(*LJtU7eSr&"?j/$gѓbc@ ?a^h>#KQ~ 9Al)귥HHvbl:x9Nvj}@n!!Fɱ!}|xD VHwjĮB2R1a!_>&H@6S#~ܰ2 W*(`c@KF*;J#q4U#T&5}p5MjhRcNfUVh5<ෑB+E*U7n^Qn| 5`3mRFw.ks\p+?rMu$MOs={WOOljo.)oߴ;Yz|E݈Fy-=!N-V^*3ׁYPK!J] drs/downrev.xmlDn0DVVBAЪ.-vdz,q47zE[v&5aLe2]z΀Fbk aSyj!( 9UCvdbwNc\:Dn(I^FeC-~'-`F;-uq]S ,P_LƓ,;l{d>m4>PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!:z))drs/shapexml.xmlPK-!J] drs/downrev.xmlPK ` \ G Conclusions: NIV is possibly effective in raising QOL for patients with ALS who have respiratory insufficiency (five Class III studies). Tracheostomy invasive ventilation (TIV) is possibly effective in preserving QOL for patients with ALS, but possibly with a greater burden for their caregivers (two Class III studies).  Z5 Z 4 HrB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 2*p(  #   x`F| 0e0e?Rectangle 2@  \ WRecommendations (      xP| 0e0e?Rectangle 3"  PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!,/drs/shapexml.xmlZQO#7~`!9mESOήC[ %lg7]l6 [fJzxTVU}Ge^1"~j oO5}Xh Ti*^Ymׇm BpV[Pqou'ZD^; 7>3׳ٱS)ѱƳi㽆&nk}峾)?ױ彊<_h򘹶 {5ձaMZl. i]5G?9Y!˟7wܘvLeu/5M5n&wŽniBRh圦fyfH/{TuBb'mk_ebLZfWV Vi%KG=i4dc+q[+ [Ax{PK!;Vdrs/downrev.xmlDn0D"q+ `P h pmmlGЯG3z7[tagr^Y#`8H)T/Oc`>XCa1|a&tޅE Ch3}YF?-bt/& רL|ʟI 8tyJd9 ]}z^uٮ ?ԇ0z')DhMoPK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!,/)drs/shapexml.xmlPK-!;Vdrs/downrev.xmlPK ` \ Recommendations: NIV may be considered to enhance QOL in patients with ALS who have respiratory insufficiency (Level C). TIV may be considered to preserve QOL in patients with ALS who want long-term ventilatory support. (Level C).  Z^g rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   xQ| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xC| 0e0e?Rectangle 3` \ S Question 11: What factors influence acceptance of invasive ventilation and NIV? 8T !D!T    N?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 1)(  0   x`I| 0e0e?Rectangle 2@  \ dConclusions/Recommendation (      x`P| 0e0e?Rectangle 3"6 0 PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!(4Z)drs/shapexml.xmlZn8/@HNQ$@v0#NǂXRw7'oHICm~ Q~Ù!G:J& x>gR:M?]_q["h%~/s_a1tV0 l\"36&EsɌ̥b4?tR+~r QrlX};L^B$睂wcۼF|0wXaCKbN}>l}7"ʩv ,ٜ RNut!*ޠ?p<3X5ǚb =OŐF=O_ j6U,%*,fi  2EzP!F ̓%u ;R,$FZKfr{KNre/d.2r[B$C[Bi0˶AT`kGʁ,*ba| +,k1<* ح#H[L+{LENJը]hob*$섐',-t#\g8MVcŊ!3[ u8Oʁ<]L*+ Ŋ׼+g Ȝ?"SwŢ.ާ <S{.09,8[id mUT)RI pE<׹z(6Qyj)܈$qE$%4UF n{h%g3H-hv!oK,Y h7FC;x #K|"9ZEloK` *ىm4ێ#!"t֌(dWeDc" Q]t*t)Lα)8=n -..Oc5Nըj j]?42}@|*fV䭪l3gK Z=jͫ4>_G-,-AZ#_+m$_e0VY[46&U4F e`k[r3;i(s.Uhs M?(-fcw^ڌy[цҿu/65!bo# `5 @]皊Z'ݳؼ5Ok< p^xv1BVv{]ϛ{[q7ۂK76jhphħdPK!%9drs/downrev.xmlDn0DV8@UP+=pm4#ۀьMQwD+k 024e4;kH?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   xT| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xS| 0e0e?Rectangle 3` \ d Question 12: What is the efficacy of targeted respiratory interventions for clearing secretions? 8e !U!e    N T| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"t7 k(     xc 0e0e?Rectangle 2@  \ S Conclusions  (       xT| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!k3?$drs/shapexml.xmlZn6;Y'^gQI豠%:V#*I;vN}aߐ&q6Œ8̐>󌭤V?pșTNRu/wY'T"2d7~sVlYQsŨ׳B~ЅThk  #TN8 g^.RϡJ߬&I?N)c[ÈLWʅ.vu`Kc1&13ܲ)T0Z`4ya~\HXzq{VSɖbܦ3l8_G|N_fsqK8m8{4.e?*Lfx43>n[2ҙGFZ#8 ޱ jZ$Hs)uw럄)$FO^@mYHIfmWBa0kx%O.̘Vhx d+J#~PIѕqMJ.b.̓Gy]f’5lFZX1H;#<[ēرZXmK9E<֢PH\ݮlrelyy>5fR37 ^ĉY[((<2OsKŤ#.)2.#0%,> zi -URIY] Xr~NϺ~wyuog' mq'PK!Kj9rdrs/downrev.xmlDMO0DHkQ)Bm[!P8mmbב)G3z\G8V0d k 7 vf"DdcRp N\q  TR%azSO n;gٝh8=cKv &wY=gvŷ>ADXCO/U+Χ ]b$dLA~PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!k3?$)drs/shapexml.xmlPK-!Kj9rdrs/downrev.xmlPK ` \ R Conclusions: Mechanical insufflation/exsufflation (MIE) is possibly effective for clearing upper airway secretions in patients with ALS who have reduced peak cough flow, although the clinically meaningful difference is unknown (four Class III studies). High frequency chest wall oscillation (HFCWO) is unproven for adjunctive airway secretion management (two Class III studies with conflicting results).  Z Z  rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +">7 UM5(  #   x`Y| 0e0e?Rectangle 2@  \ WRecommendations (      xW| 0e0e?Rectangle 3" PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!\כ)drs/shapexml.xmlZmO6>i׉[( &U\&.HvK~ɞc'i1]\T"sy"\jOۜI$UzuuuB%"JFNZ-*+/">uw:6\O emr5םH+YTc4bh(_̇Iw{;)KcיdSʅ*ƖLb-f2SAl1v*Eb5VcU*2wW`cq ~^wy{W h`9W9ɸ)j>?(95΄*p״Șɸۢf<2Bh5⎳ٍ4cRlT_|0R";_64ZO|:I)L "8ST<Ͳ`YK NA9n(*kJ\W35S=xΙ)W[+l#7&|W`%&UD I#5)`6,#79lE8WrNscD;kO{]*h^a/oǀiaWO&6Eyx& Dd(9з|yK!يkgAROخĶ<$Z"_C?}soO=*m*Phe=.1r=,WY!V>ڳѮ6Bų64ճشF<{vڼj{eu-+NzYYؓnބkNDַik5[IZ u@$mq/PK!_drs/downrev.xmlDMO1E&晸`GP\ap1}T}௷q˛{sn|V)D㝂 AڸZ\LADF)rqy1\+Z$9*h\X5d1|G.u{,r:)m+GY6K vP9X;3wQ>gvk_~>@0?~o;V0g /]0$dLA.~PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!\כ))drs/shapexml.xmlPK-!_drs/downrev.xmlPK ` \ &Recommendations: MIE may be considered to clear secretions in patients with ALS who have reduced peak cough flow, particularly during an acute chest infection (Level C). There are insufficient data to support or refute HFCWO for clearing airway secretions in patients with ALS (Level U).  Zo 'rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 z(  "   xY| 0e0e?Rectangle 2@  \ VClinical Context   $   x`S| 0e0e?Rectangle 3 ` \ XMedications with mucolytics like guaifenesin or N-aceylcysteine, a B-receptor antagonist (such as metoprolol or propanolol), nebulized saline, or an anticholinergic bronchodilator such as ipratropium are widely used; however, no controlled studies exist in ALS.    rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   x@X| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      xV| 0e0e?Rectangle 3` \ I Question 13: How should a physician tell patients that they have ALS? 8J !:!J    N`V| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 5-(  /   xY| 0e0e?Rectangle 2@  \ cConclusion/Recommendation (      x W| 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!lצu"drs/shapexml.xmlZn"7wX (*A"˕1aʌ= !; $=3R`WIw09g`)I Y) T}\X.c*)B( ˼k!Yw D; hFr:=x"YK8iE7ˑ8d $ϰ}*Q)| U4730knHQSgM\ifdžo1X**ˉ_;[b'Ʈ1wɻq(J?AsZ U0f I[hЛ#*upaՐYjߢّrnrGDHgɵw\U1Ix._%T7i]@Ǝ#~ $[ɸ muNqvn(#1zNJ CRbz'Bsk=w(OWnʄFØBww6`VXbMq5咠+F'~VbTU8Iոq$Oy:-K@ĻEdcCLȓOcX$غ 'pW.B&,̡R]s!G ]UtIRi$~qM F qZ\MAuL `c݉ :nb-C \P5d1 ]Gc)m+Y -N vP9X;3OQfv:|(u{?=Ǡ(RZ~:ؿwC$ %d r PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!lצu")drs/shapexml.xmlPK-!zdrs/downrev.xmlPK ` \  Conclusion: There have been no controlled trials of breaking the news in ALS. Recommendation: There is insufficient evidence to support or refute any specific method of disclosing the diagnosis in ALS (Level U).  ZFx Z Bl rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +" 7 !(  "   x]| 0e0e?Rectangle 2@  \ VClinical Context      x\| 0e0e?Rectangle 3 ` \ {Useful strategies have been developed for disclosing a diagnosis of cancer (see appendix e-1 of the published guideline).4 2|y|  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   x\| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   z   x Z| 0e0e?Rectangle 3` \ D Question 14: Does multidisciplinary management improve outcomes? 8E !5!E    NX| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7  (  1   xZ| 0e0e?Rectangle 2@  \ eConclusions/Recommendations (      x`\| 0e0e?Rectangle 3"L F PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!xK'drs/shapexml.xmlZN#7w|[lXHİ$J^"g!Sf?ϱĥʦZ(!9E.*/I'1:;66t"5'88<,# 89ݘ(XKuX-i`C\Tm%,FR Ž(-C;!#O"E r:]uP߆* w*yh;E+rW({(Y;_#d?+lLUF١4NRpO,G/^'1.\qyE)2ZWn5-sY?Wy&"߱V)B=\Ѣ-t5`|m)k3oz2 ~'zF%YѦxp%sZEm-fl˖@]fKhO}fE/50 n*ѾeS2=Gw|E*+\?+H储xQNaVƻ @څS}ŷכj$Y5-Q+ڝ场ZBWaxЮz#%&(0ԙ˜*Q[WlIj<-7*q73ǃ`SuWk|U?YPK!Kdrs/downrev.xmlDn0D"uW Ԋ>V(Mwb;HhFgtNB+kG 02ʔi4kkH@OVSi&.,BOQ@Br4mh+txp]Ipć z8Z-&{D7]a~ q{wԗ0})DhM/PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!xK')drs/shapexml.xmlPK-!K4drs/downrev.xmlPK; ` \ yo Conclusions: Two Class II studies and one Class III study show that multidisciplinary clinics specializing in ALS care are probably effective in several ways: increased use of adaptive equipment; increased utilization of riluzole, PEG, and NIV; improved quality of life; and lengthened survival. However, one Class II study with low use of treatments found no survival benefit. Recommendations: Specialized multidisciplinary clinic referral should be considered for patients with ALS to optimize health care delivery (Level B) and prolong survival (Level B), and may be considered to enhance quality of life (Level C).  Zn n{4 prB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 0(  &   xZ| 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   }   x_| 0e0e?Rectangle 3` \ G Question 15: What are the most effective treatments for sialorrhea? 8H !8!H    N`P ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 @ (   1    x`_| 0e0e?Rectangle 2@  \ eConclusions/Recommendations (  M     x Q 0e0e?Rectangle 3"M G PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!SvDR+drs/shapexml.xmlZN8_i!)t@+]BeM\%[ W$;?MRI%89`!I ޻]87!tuscyٽ0, |h&2nީ\HMθEUtr-[,NɎ1\Rt CwgIEu :?nM fbTklekV'Zౡfq JJr{!un1AW=)F̀{\7 j,2̹,HL׃՞jgg*upa֐YE #8kcqT j鬶̉(γ$'ڱ:|#!?KD֩SdZ 3 2PUaFFVLlDx5GNЫe=5&=V\弙cu-nڦF즼lȋthQ\L[lCho8̫fv+&*gKzC22uif3,?Line 4pprB   J>?Line 5   33y___PPT10Y+D=' = @B +"7 P(  "   x@^| 0e0e?Rectangle 2@  \ VClinical Context   <   xQ 0e0e?Rectangle 3 ` \ pIn ALS and other diseases, anticholinergic medications are generally tried first to reduce sialorrhea, although effectiveness is unproven.1 Botulinum toxin has been effective in controlled trials in Parkinsonism as well as ALS.5 XW  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 `(  &   xQ 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   ~   xR 0e0e?Rectangle 3` \ H Question 16: What pharmacologic measures reduce pseudobulbar affect? 8I !9!I    NW| ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7 p(  /   x`S 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  F    xV| 0e0e?Rectangle 3"  PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!+|"#drs/shapexml.xmlZn6;Y'^gQI1%:V#*I{}>I!EIv l.|Hΐ~C"VBLɘ9dJ3w,2˔J= ޟY92eҌʘ--GI*mt-Wjab" IvjZN4DGYӣ!$/0H C.W.rUh*aKI5nIR0Z`6q<5Ԍy{N $KS )g*}b~A8;~4k5X[]_XZ3>jUߖ\ ?K,fx4@U'}Tt2kS䲸RC̲,j蝨v,eBR{2":Q/c૱jU= 4Hn>A;Bi0ˮA1kGց2b p+gQ*w|6}T@[Gԏ幒uqCJé]hobN2$윐'LL8t#fmVǚC4s_E-r}v ϖxԕXbkȭ; 8ecELȃSX$?%gp\Lb 2X:{yjJ,z B⢭&IV*ϞOJ:Gh殜f>)U.$%=<@SyRmƮE\b> ,DzBoITeərPȃܒH--Bb=<mY"oG`w<d١CgUp(xCʡsmQ;#9Q~ 0MG 1?ۏseveù[]}l(4Dկ"` /ߍ U?pN#?oQ! ǧbn >g+^fg܌Jl MQ7x:]Ёos۹&6O}'z2H\raC]& LuMɆ1dMY%ޡLŚѷImNHu~.b_vΫv^Zv 3`yižaV._ y7ez=gzA<\(/PK!=drs/downrev.xmlDMO0DHkQ)Bm[!P84pۑiS~=8fFom'Nt W{m\`Wmn "yG aXbɕtr#}!e[''9HඓyIƥ{zlV;..63~Ib._ԫV0O /}0$dLA~PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!+|"#)drs/shapexml.xmlPK-!=drs/downrev.xmlPK ` \ hl Conclusion: The combination of dextromethorphan/quinidine (DM/Q) is probably effective for pseudobulbar affect in ALS (one Class I study), although side effects may limit its usefulness. Recommendation: If approved by the FDA, and if side effects are acceptable, DM/Q should be considered for symptoms of pseudobulbar affect in patients with ALS (Level B).  Z Z  mrB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  &   xV 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   w   x T 0e0e?Rectangle 3` \ A Question 17: What pharmacologic interventions reduce fatigue? 8B !2!B    NP ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"_7 vn V(   /    xT 0e0e?Rectangle 2@  \ cConclusion/Recommendation (       xT 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!Oj8drs/shapexml.xmlYn6;Y'^gQI豠%:V#*I;vN}>I!EN *@!gHp`+ilUOs&U\=&9g B+]T#[1 VvT%|\5lot%xsmJ4H+ E|W\KLVjbJV,o'CΔ(Lc![ޫ=:}2sɌxw`JhoXM^Rdn+uUPtm*h9نCu`?<aLb~3n}bD3`ׯ ꀃ6/=]ߗHΊ63< `iӳ>f3ey P)fM,7-NuY 7V*%AKe{X"Lň vwzb5PݖMRX7u}OH Vw? S 3ch{PBG2E Q<» 29Km݅1Rյy(ϵrW~LX2Fl ;Y BԳU:I[ L _@x[Z_QLJ\k8%jlySy4-v4A`y1 ;Qxe<`M'\SD$?'gp\&\a X&?*=gOOj):REySz,7n)[B ?#i\(z*}EDۃ9o&P[QpM3,#~#$f\v &UPb^_$dԭ3Rx5E`n31ZƑsR}N*U6Fb;` wP -B QInQKnZ̖.:W99pyW.n/ᵧU( "+b,bw UL@_?VLmƫu+vNj3diX ^>V r;.[xњkz|_p ضT}A0-.~Bm >[o muPK!8Fdrs/downrev.xmlDMO1E&晸1B0l=u6.tyso͙-zۊ#`+2ĕӆkry;"1)8Sbv'.踎H9*hbr)CՐ0pq[)Zjeكh8=4KC`hEr?}U~q+Q+`|7NA;ot!Wm29PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!Oj8)drs/shapexml.xmlPK-!8Fdrs/downrev.xmlPK ` \ Eg Conclusion: There are no controlled studies of pharmacologic agents relieving fatigue in ALS. Riluzole may cause fatigue in some patients (two Class III studies). Recommendation: In patients developing fatigue while taking riluzole, once risks of fatigue vs modest survival benefits have been discussed, withholding the drug may be considered (Level C).  Z  hrB   J>?Line 4pprB   J>?Line 5   33y___PPT10Y+D=' = @B +"7 $(  $& $  x@X 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   r $  x]| 0e0e?Rectangle 3` \ 0 Question 18: What interventions reduce cramps? D1 ! $!1   $ N^| ?Rectangle 4 i  ( $  rB $ J>?Line 5rB $ J>?Line 6   33y___PPT10Y+D=' = @B +"7 .&((  (/ (  xV 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    (  x W 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!LjYdrs/shapexml.xmlYn6;Y'^gQIc@KtF"Uv}>I!EgH7v ,* 93Ñ>.˂-V ?zwșTrOwY'T& dŸ؊AXAsՠӱL¾ӕTjS yTFZpX,:R䊟c*W#CTzg ;=sDeoe % NDʈLfvSgaM}5j4"vQWUIjs-':{P~^8k V{سߌ[^BL h?8hٓؕ}.Ua3^v;>cG&#j^^##TY8 Cҩ.+j\H{uwTHɥ㙨gu:hº{w`]g>0C:!ޭX%U!xWY&wb2~M@ #P]GT+wE&’5M\X$]򤞭QB`Zh r lX1ŊbyG'-=ȓ!sYˋ^@I (?˼Կ[l:R|#")a? < KP2#Q鱧8{JPsQ+EQ_/K9:?62ZO=={ʖHJ_E"Pl)-CDֹtPљUޜi|șzT‘@)@jR[ `w<M@ j !c"8EAm  6L(V1tOO[ ؿ)伞/rDY"uUhxka) ?COre;PZhREPX^Ʈ'6:qp+ȓ05um|K>v[Re#a](׾ݯ}+C/Xl3ggML{ZWIlNjBWJh Ho}G[$H}HZ+aB MӐq őKPu(c&7}i23~}X)nUYZ!ak&i{'w`cPK!1fyndrs/downrev.xmlDN1E&CLȃ0l=괝ƅ.o͹9EoZqdAm唶5¶\O@HVQ,#9b~}5\-HrBhbr)Cհ0p7STN nZ9ʲGiHP/ WߛAі.Et9:|"O "[]E}(d8?V!%d rPK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!LjY)drs/shapexml.xmlPK-!1fyndrs/downrev.xmlPK ` \ % Conclusion: Studies of gabapentin, vitamin E, and riluzole for treating cramps were all negative (Class III). There are safety concerns about quinine. Recommendation: There are insufficient data to support or refute any specific intervention for the treatment of cramps in ALS (Level U).  Z{ o &rB ( J>?Line 4pprB ( J>?Line 5   33y___PPT10Y+D=' = @B +"7 ,(  ,& ,  xZ 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   j ,  x@R 0e0e?Rectangle 3` \ 4 Question 19: What interventions reduce spasticity? 85 !%!5   , NS ?Rectangle 4 i  ( $  rB , J>?Line 5rB , J>?Line 6   33y___PPT10Y+D=' = @B +"7   0 (  0/ 0  xY 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  Y  0  x`Y 0e0e?Rectangle 3"ëPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!lJB|drs/shapexml.xmlYn6}/Zd}YgǀXD$y?%=CJ]`[`< gǹ`-I Y]BF*NS>=ܞ]X.c*)B}U>0y -"ʅD\[4S+iBYZO$b*MRt Cw@ ދF<"xZaXEKS_cL3vX#Wt-Z=/ ƺ-g`idK63o߄.bWmnn0rx4q}VP ~aؕsŵ`Af^;袡{f=rT2¬!,ȢёrnrGH{ɵ\$6NM<NaIRcv  *&2tB6ֽ!]%HdRO?pnF/s%2㆜E7靬dE<)!O . P8*K2GŦC&٧)2^3{B&%,,RMĂp# B*^IRi"~sM?Line 4pprB 0 J>?Line 5   33y___PPT10Y+D=' = @B +"7 5-4(  4" 4  x@R| 0e0e?Rectangle 2@  \ VClinical Context    4  x`V 0e0e?Rectangle 3 ` \ In multiple sclerosis and cerebral palsy, benzodiazepam, baclofen, dantrolene, and tizanidine are effective in reducing spasticity-related symptoms.6,   rB 4 J>?Line 4rB 4 J>?Line 5   33y___PPT10Y+D=' = @B +"7 8(  8& 8  xc 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   x 8  x@U 0e0e?Rectangle 3` \ B Question 20: What pharmacologic interventions reduce depression? 8C !3!C   8 NW ?Rectangle 4 i  ( $  rB 8 J>?Line 5rB 8 J>?Line 6   33y___PPT10Y+D=' = @B +"7   < (  </ <  x` c 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    <  xc 0e0e?Rectangle 3"ÛPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!0oo3Rdrs/shapexml.xmlYn7}/ Z8D-඀`<.emKnIJKzbGj!9<ÙÑ>-Vokr&UT=F%g L+c矮-&++">s56\w cSmr4H+Yl~h"Ur\ Ȱ4e˙91x${\"Ps[*#^LbNSW̰6F?ͤH,uc߆WUAUҥ1.D'kWﴻvgq_\(0&g(誢KQgoYJΏS_OR־fs7Ȥ+ƙR4*=h:K 8۸U(خN*tCUeʺ>LE =Y΢'a -o >#OQ~!9jCi/H9k+6'rPڗ$By/6"Ė/6fX"wt!NM.B Pl*T۶g/n~H* #֫Gj;նE<$PU>|:$:c8S<#{lSe9ߎYUY'84C, $i)ݣ~V8/&-ۤLf/ٴ*PJz",Vц^Zl[e~ZտWڢ/PK!,:drs/downrev.xmlDn0Dkz+PUbP[D[Iěۑm kь-VnٙW`dJ+ h$֐+yX- LyY&.ܗ i#ۑ]etxpIpć;h<'-`&;͊D7Ӱg-{hԷ0})DhM/PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!0oo3R)drs/shapexml.xmlPK-!,:drs/downrev.xmlPK ` \  Conclusion: There have been no controlled trials of treatment for depression in ALS. Recommendation: There are insufficient data to support or refute specific treatments for depression in ALS (Level U).  ZKg J\ rB < J>?Line 4pprB < J>?Line 5   33y___PPT10Y+D=' = @B +"*7 A9@!(  @" @  x\ 0e0e?Rectangle 2@  \ VClinical Context    @  x@[ 0e0e?Rectangle 3 ` \ There is consensus amongst experts that depression should be treated in patients with ALS7; however, there are no controlled studies of benefit or harm. 4Y?   rB @ J>?Line 4rB @ J>?Line 5   33y___PPT10Y+D=' = @B +"7  D(  D& D  x[ 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   u D  x`\ 0e0e?Rectangle 3` \ ? Question 21: What pharmacologic interventions reduce anxiety? 8@ !0!@   D N^ ?Rectangle 4 i  ( $  rB D J>?Line 5rB D J>?Line 6   33y___PPT10Y+D=' = @B +"x7   0Ho (  H/ H  x ] 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    H  xY 0e0e?Rectangle 3"ÚPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!/@drs/shapexml.xmlYn7}/ Z8D-඀`>.𳾰ԱKǺ!9<ÙÑ>-Vokr&UT=F%g L+c矮-&++">s56\w cSmr4H+Yl~h"Ur\ Ȱ4e˙91x${\"Ps[*#^LbNSW̰6F?ͤH,uc߆WUAUҥ1.D'kWﴻvgq_\(0SGQcɬj^ L2|җ2|mUf(U$2y= U֪IhCB/}`7*TmPK!rNdrs/downrev.xmlDMk1ECxBw5XN"-Cb{N3i'ɐD˽˙;ݰ90$ȔV*S ˻10Hl!0nI{69֡bb|ڌs_֤lK&v4]ťs놧I5*jl驦{}*O^$z:wG`pl*/PoR~<;^N} ' Eh | PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!/@)drs/shapexml.xmlPK-!rNdrs/downrev.xmlPK ` \  Conclusion: There have been no trials of treatment for anxiety in ALS. Recommendation: There are insufficient data to support or refute specific treatment for anxiety in ALS (Level U).  Z=c <X rB H J>?Line 4pprB H J>?Line 5   33y___PPT10Y+D=' = @B +"7 @L(  L& L  xb 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   n L  x a 0e0e?Rectangle 3` \ @ Question 22: What pharmacologic interventions reduce insomnia? 0A !2!A   L N`_ ?Rectangle 4 i  ( $  rB L J>?Line 5rB L J>?Line 6   33y___PPT10Y+D=' = @B +"y7   PPp (  P/ P  xa 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    P  x@^ 0e0e?Rectangle 3"×PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!U.Ddrs/shapexml.xmlYn6;Y;^gQIゖXD$9}~CJOZl6v , R3pyTr&UT=Dg L+ŏ?C[0LVvXD|\1tlF o2dxlSJfHu5:HU蕴LO:Y " vg 0vw(md{:K# ؠdEv`B9gۄBaUJ$P M KSb(3$ÐK%]r!Zh|NX7DCg+X* #pUF{UF?Line 4pprB P J>?Line 5   33y___PPT10Y+D=' = @B +"7 `T(  T& T  xd 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    T  x_ 0e0e?Rectangle 3` \ h Question 23: What is the prevalence and natural history of cognitive and behavioral impairment in ALS? 0i !Z!i   T N` ?Rectangle 4 i  ( $  rB T J>?Line 5rB T J>?Line 6   33y___PPT10Y+D=' = @B +"7 pX}(  X/ X  x`c 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    X  xc 0e0e?Rectangle 3"PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!SY%drs/shapexml.xmlYn6;Y(@F`YXH;C߰OoHI y(o8u+Md:,2Rq"BrTI0?\, |jh.2n>\H͔θES?r-[LnDkI>$E8d{> $0탈S*U!~T03-Ě?c;~RT9f7Zౡט,}p|r ^E^0]b#,`o_ j/,x2.,HXL!5z]4tgZlR ̲CFG*˹I"%>:H j2p |52P뺦Nq?LY >#ڡ~kG^$2VY'=nGV/3%2冂S#n ;^xSB3y4l0 Gp+f8*Ll5nfv_4 wq@.'/xT{dbGȃ; 82K2GŢC&ٗ 2^S{.C&1%,,p8 Gt -ڪx%)Kɋ5 4\ZDۍLf"yJzJuiMIL/]rN>6v3 "VR]r$ dvp)g#S&RKq:L3^tm<)Ȝ>VM Ȉ`79=贝P.@(.б* {y~A!Pڎ|QJXLu-_T>ѝ\z BEA]!V-'9[{K&ͪ w̼~\B5W}&/oB6!74Nn.k׮k-",vh[sT>Y(MY}=gsStK92* M}\ƾ[lWo2Ak _vZNpnv&*C0QDBWT܆P{\trM~/PK!12drs/downrev.xmlDMO0DHkQ-PBq޶61v۔_[ۉ`+2ĵӆj}7"1)Pjvg.鴉H*hc )Cݒ0r=q[)FjdLZ4Z驥ks fzl<@Dxs?+QoZ~>A^/{ot!Wm2PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!SY%)drs/shapexml.xmlPK-!12drs/downrev.xmlPK ` \ } Conclusion: A significant proportion of patients with ALS demonstrate cognitive impairment and some have dementia (two Class II, multiple Class III studies). Neither behavioral impairment in ALS nor the natural progression of cognitive or behavioral impairments have been adequately studied. Recommendation: Screening for cognitive and behavioral impairment should be considered in patients with ALS (Level B).  Zi ] rB X J>?Line 4pprB X J>?Line 5   33y___PPT10Y+D=' = @B +"7 \(  \& \  x g 0e0e?Rectangle 2@  \ ZAnalysis of Evidence   x \  x` 0e0e?Rectangle 3` \ J Question 24: How is cognitive or behavioral impairment in ALS diagnosed? 0K !<!K   \ N] ?Rectangle 4 i  ( $  rB \ J>?Line 5rB \ J>?Line 6   33y___PPT10Y+D=' = @B +"47 KC`+(  `/ `  xe 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    `  xf 0e0e?Rectangle 3"øPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!5_QNdrs/shapexml.xmlYn8/@HNQ@v0#NǂXkԒ?/7$N[rPp8|ÙG&yVT9LX'zsά*V2OrQ l0YAsŠӱ\¾хTi yFZpX(:w\_”ZM!)] K흟9S"Dzw2doy SxaKgkIx`Jns&яs)KX|Up|)=r'una`W=͸5f^^Y߾m9{4,e*l!7zg]4LsdQ|3P1FqġC cԤIR S01IݭE!X#T` #u *ZF\n{G΃:RG+,{1֪0Ѹ]$⺜< vR7nQAy1 w> P:A2OswŦ#.ч *.#,.JOB1%CEG]T>?| Ru~lly9I{0[$3E_o,,M76Jb֡ bM-9U,GDoIfJ_rf"(sg1bg@0۝ؖ'%LD@rX3=#F T(L(g SlP(*B鞟 ԿP=97&b756|QF5ͰPC.\vɅh@տY-}XjwmZ d֘LwmU6OR%ca_Qi{_6wٳc_cFcEL~"wk Tϣ/׬ھD2 *H=߾Weg/o /GṃSK$l4ZRcbcWvTáTnlեŶzf@l58{rϵ?imq?PK! drs/downrev.xmlDN0EH5HӇP֭PQyPnMɣvۄb˫{ujӛV\Ʋ(A\Xp |@Z&yجooVj{.Pa:.5#Ǯ`UR;Fi$ICmk*gL/YOg%@}lyV/M+u8Fg9/FSPK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!5_QN)drs/shapexml.xmlPK-! drs/downrev.xmlPK ` \ 6\ Conclusion: Neuropsychological assessment is possibly effective for identifying cognitive impairment in ALS (one Class II, one Class III). Recommendation: Screening tests of executive function may be considered to detect cognitive impairment in patients with ALS prior to confirmation with formal neuropsychological evaluation (Level C).  Z  ]rB ` J>?Line 4pprB ` J>?Line 5   33y___PPT10Y+D=' = @B +"7  d(  d& d  x`i 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    d  xc 0e0e?Rectangle 3` \ k Question 25: What is the effect of cognitive or behavioral impairment on management of patients with ALS? :l  !$]!l   d Na ?Rectangle 4 i  ( $  rB d J>?Line 5rB d J>?Line 6   33y___PPT10Y+D=' = @B +"7 h (  h/ h  xg 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    h  x@h 0e0e?Rectangle 3"óPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK! Idrs/shapexml.xmlYQo"7~kpPSPȩ5aˮtػ U\NŽ=xf  ;oȒLxlq yi{W"d[P (Q,X @>"g(誢KRJc 4XƦZDۭLfǩnE8JuiMIL(KB)iw\YzɳԒP@d"S a<F&C rz[8W#-Z$ Vm'N(H(Y3[U wuqIߒP M ~9e*KE-db`:{Uma^j]E#lSE_YUaC*L>*\Vt1>^{[[}_`fIDJ]Pˮ|9N_;ʾWk5|YxXRuҜ͟}^mͿK7qo}ca M>PK!drs/downrev.xmlDN0DHH\u"Ԇ)M/ܶ&1vdo۔ь-VđB4)2*k Ddt;H" ̵?[nDϥUKRW`S O n;9ɲ{iѸbOO-U_ۃU7~Kf)oiq|+QoZn6_`t)(H~6\PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-! I)drs/shapexml.xmlPK-!drs/downrev.xmlPK ` \  Conclusion: Insufficient data exist on the effect of cognitive or behavioral impairment on the management of patients with ALS. Recommendation: There are insufficient data to support or refute the impact of cognitive and behavioral impairment on management in ALS (Level U).  Zz yy rB h J>?Line 4pprB h J>?Line 5   33y___PPT10Y+D=' = @B +"7 l(  l& l  xk 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    l  x@e 0e0e?Rectangle 3` \ [ Question 26: What treatments are effective for cognitive or behavioral impairment in ALS? .\  !$N\   l N d ?Rectangle 4 i  ( $  rB l J>?Line 5rB l J>?Line 6   33y___PPT10Y+D=' = @B +"7   p (  p/ p  x j 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  E  p  xj 0e0e?Rectangle 3"ùPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!TXQdrs/shapexml.xmlYn6w x;N\E #0,hHFRpOi3 QH<xuZ6\7 mmrP5H+Y}|T>RQ14Պo$ť;'Δ1흌C&[ުB=:ʴ2%$ F mݣ9a쥷/s]`$dLA.PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!TXQ)drs/shapexml.xmlPK-!({drs/downrev.xmlPK ` \  Conclusion: Data are inadequate regarding the effect of NIV on cognition. Recommendation: There are insufficient data to support or refute treatment of cognitive or behavioral impairment in ALS (Level U).  ZDv Ci rB p J>?Line 4pprB p J>?Line 5   33y___PPT10Y+D=' = @B +"7 t(  t& t  x`f 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    t  xg 0e0e?Rectangle 3` \ L Question 27: What treatments for dysarthria optimize communication in ALS? :M  !$>!M   t Nm ?Rectangle 4 i  ( $  rB t J>?Line 5rB t J>?Line 6   33y___PPT10Y+D=' = @B +"7   xw (  x/ x  x`l 0e0e?Rectangle 2@  \ cConclusion/Recommendation (    x  x@n 0e0e?Rectangle 3"ÝPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!ƪ5Edrs/shapexml.xmlYn6}/Zd}YgǀXD$y?%=CJelX@zWY6!k@Hʼn| ٧۳KeS%E6°ß&0XA2BdܼS+q~jZ!-X(K[vC+dCL%W|IV$q.;}Ha{TYC8hiJck5Uc+F &V cCnX*a*ْ/aL!un1v{v^̀{\߾8_X9ve,,HL5z]4nlGH.#2/,Z,v,yD\uAbmtsjl,$5vj7`r,n'zL'och;P‡D8!;4xJYM_J֏|,oҡ' P="#] C,Q]-_Ժ>ѝ\z  BMAkT N~ZF@ #! Wo(_4oi[}OUWOViBErΑ=o笪l SU#B ɕMyh.c?e?554MT/A%L¶bՍZp7e Ly=W6up[O ɇPK!^drs/downrev.xmlDn0DV8V4p /!#@kqhFo^D+k  026m 4[kHCM]ƹ#uC9uGI5*軡>j[5(=Ya՗ߏ/'@}xWye~/o`uJ9/FSPK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!ƪ5E)drs/shapexml.xmlPK-!^drs/downrev.xmlPK ` \  Conclusion: No controlled studies examined communication in ALS. Recommendation: There are insufficient data to support or refute treatment to optimize communication in ALS (Level U).  Z;j :] rB x J>?Line 4pprB x J>?Line 5   33y___PPT10Y+D=' = @B +"7 |(  |& |  x`p 0e0e?Rectangle 2@  \ ZAnalysis of Evidence    |  xn 0e0e?Rectangle 3` \ U Question 28: What treatments reduce pain and dyspnea in the terminal phase of ALS? :V  !$G!V   | Nl ?Rectangle 4 i  ( $  rB | J>?Line 5rB | J>?Line 6   33y___PPT10Y+D=' = @B +"7    (  /   xi 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  D    xm 0e0e?Rectangle 3"çPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!| =<kdrs/shapexml.xmlYn7}/Xpt[W-m,y4]jܒ,? ). R } !"BLɘ5Y$dL>%2幒"fka?]=SF,Mڲhd& nީRHM.EU?5J-[,TvQL>q9$%wˑ4f;.$/H`S.C8dn6jIVZXS fXM\kgnl0l)g]r5uNE{1v{v_̀{\߾8_X9ve\p-X.nӁt/ڨݞn\;dL0k,8atۡ )^Jm3eD"S/Sˡꮮzhر]GBeʱI!vv@ȗ@ Lqcv4xY_6. ح#PCyvC&ܐ5rӍ!t6qzG `vNȓyLF:UCUc)S{ަwa@,/xT;db{Ƚ:N <_YCM]ƹ臶#uC5uI5*赡=k{5wQ=їכX>|Yw) LG3`m,r_?PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!| =<k)drs/shapexml.xmlPK-!’drs/downrev.xmlPK ` \  Conclusion: No controlled studies examined treating pain or dyspnea in late-stage ALS. Recommendation: There are insufficient data to support or refute specific treatments for pain and dyspnea in terminal ALS (Level U).  ZRy Ql rB  J>?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 % (  &   xr 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x`o 0e0e?Rectangle 3` \  Question 29: Do hospice care, spiritual interventions, or advance directives improve quality of life in the terminal phase of ALS? :  !$v!    Nh ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7   0 (  /   x q 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  I    xq 0e0e?Rectangle 3"åPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!^<rdrs/shapexml.xmlYn6;Y;^gQI1%:V#*I9vN}aߐ (eH78eG Md̎?tY$dL>2幒"f+a8/0Ya1\|P)]p~Z!-ب;nSdXJ.&X.:Ҙ}X$ymD#s}dZOc'SbL3NeG$G9ƞzĥy.xjvV SɖrU +*]1Y7>'<g58;]^a9 8GC-pPEϚT揊kW }xںF䴇nȪVC̲ȋ-NTQr;2!E:K_uIbiodKbd,Z$7vbW`*nzD77h9PBG&S\ ?"rbvϧs+P)i/ݔ)74D1&n︒ 6` w. P8姪 {šc&ї 2SV1؂ΞRMĢ'' ]UtIRy"~qM<(׹Vj4v$S\p"YKJuy@ہ,Nנ(]mj .Sd^EԲ.x;*Qn|(΀~ 1;oۋ"]@j#Ϟ n=r؎ JVm&S |M(VPzg'-o"#MhX"M5_4_>\- BCQHQt! BC~c]l6ЀwhBc9w(qk}ITg k*h:pӆe=_[lsV=ےP9iOPBrz[2<{ڪ+~7_4EKZNak BZגRCJ_{o9ogn-.[ֳєPK! E drs/downrev.xmlDn0DV8TAAU+=\z[%qۑmB[ݲWHG 02b45$BVfҞMN>,ʰq4tp?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 @(  &   xS 0e0e?Rectangle 2@  \ ZAnalysis of Evidence      x`` 0e0e?Rectangle 3` \ b Question 30: What is the optimal method of withdrawing both NIV and invasive ventilation in ALS? :c  !$T!c    N m ?Rectangle 4 i  ( $  rB  J>?Line 5rB  J>?Line 6   33y___PPT10Y+D=' = @B +"7   P (  /   x`L| 0e0e?Rectangle 2@  \ cConclusion/Recommendation (  D    xS| 0e0e?Rectangle 3"æPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!r<ldrs/shapexml.xmlYn6}/ Zd}YgQcAKtZ"Uv<!% l6v , x39:Jjλ6gR:IS?=ޝ]rfPȴH?^U1`eEVs NRoM.Uira{/ ]TX;׮oH׷-!xJcy yhx ęN*򐌎`M|=fU)g*n}U( ?Oe{&_`/&;xs?Line 4pprB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 `(  "   x)0e0e?Rectangle 2@  \ VClinical Context   K   xz 0e0e?Rectangle 3 ` \ Protocols based on consensus for withdrawal of mechanical ventilation in intensive care units (Class IV)8 include counseling and symptom control with opioids, benzodiazepines, and anticholinergic medications.9 We could find no controlled studies in any disease. Fhg6   rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"O7 f^pF(  "   xR0e0e?Rectangle 2@  \ VClinical Context      xR0e0e?Rectangle 3 ` \ $This evidence-based review indicates some progress in evaluating new therapies for patients with ALS. More high-quality studies have been reported leading to more confident recommendations regarding the value of NIV and PEG.  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"v7 m(  "   xR0e0e?Rectangle 2@  \ VClinical Context      x R0e0e?Rectangle 3 ` \ KIt is one thing to publish an evidence-based practice parameter for the management of patients with ALS, and it is quite another to be able to track adherence in practice and to determine whether the publication of evidence-based guidelines has changed outcomes.   rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"Z7 qiQ(  )   xR0e0e?Rectangle 2@  \ ]Clinical Context, cont.      x`R0e0e?Rectangle 3 ` \ (The ALS patient CARE database was developed with the hope of standardizing new and effective therapies for patients with ALS and tracking outcomes to raise the standard of care.10 Data obtained from the ALS CARE program have shown that the underutilization of many therapies (especially PEG and NIV) has persisted in the years since the original practice parameter on this topic, though there have been gains. X33   rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  )   xR0e0e?Rectangle 2@  \ ]Clinical Context, cont.   X   x R0e0e?Rectangle 3 ` \ :These findings suggest that an evidence-based practice parameter may over time become more widely accepted and change practice. However, the persistent underutilization of therapies that improve survival and QOL poses a challenge for ALS clinicians to continue to raise the standard of care for patients with ALS.  ;:;  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  !   xR0e0e?Rectangle 2@  \ UFuture Research      xR0e0e?Rectangle 3 ` \ lThis evidence-based review indicates some progress in evaluating new therapies for patients with ALS. More high-quality studies have been reported leading to more confident recommendations regarding multidisciplinary clinics and symptomatic therapy for pseudobulbar effect and sialorrhea. However, future research in the following areas is still greatly needed. mlm  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +" 7  (  (   xR0e0e?Rectangle 2@  \ \Future Research, cont.       xR0e0e?Rectangle 3"ÕPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!t,!drs/shapexml.xmlZn6;Y;^FEb m#0,H;C߰OoHٖ ,mi(7f(WyVT~hs&UT=E%g L+-+/">wZ6\ u3mrP4OH+Ynr*>@Wj5)Ɔn56,M"m?rDae #2>V1–ƈ`Jl0Ss&s)K1nUT3)`T'װ/:]PFZOƭorp%p8hٳ}),Ua2nv=`5jZCydkgA::y!HMi.aEFrd. jdZuY7qHH0 F9 3|tAVT%X?\]ȞDtR`wh#uc^i}4Fimb* meFȓyDZc+A h١.SE{;v vfaQ.'/;SBz" O.y\p1Kuy;0M *ˈ+ Aˤ R鉗8[H@?&6ZVHQ/YJ׍3/'q/ 3)|dqmeaA'VgiB=%p qRಪ,GDoIݔ_>D ;IJ?G+oh%@&NxTW?߃4ŸD?$IoB3׆_ǖ{cU`{>P;5ID%2C24ڠ}oW8K6S=NN!pWJ^)NnyK*yj(uīq{y+Lc?E|j)c_pzm(f!#y2rRņo qqϳ%ݚA 0͙D$5w |au7qd.}`{PK! 9݁drs/downrev.xmlDN0DHHܨMUVT&޶61v68q47z`:v$nG)m U YpsN&6,AlQBcs ɦnoxJpnPbOO-՟ E*8lE޳$܉$=VH^BKPK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!t,!)drs/shapexml.xmlPK-! 9݁drs/downrev.xmlPK ` \ 5Lithium carbonate Study whether lithium slows disease progression or prolongs survival in ALS in larger clinical trials. Nutrition Develop ALS-specific indications for nutritional adequacy in ALS and for PEG and radiologically inserted gastrostomy (RIG). Study the optimal timing of nutritional therapy administered via PEG or RIG. Conduct clinical studies of novel antioxidants and supplements . vh  h   rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7  (  (   xR0e0e?Rectangle 2@  \ \Future Research, cont.       xR0e0e?Rectangle 3"M G PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!vw8drs/shapexml.xml[_O6`u &U\K3'sRxapdcI(};>؎se&l&ug*ໟڜIfQnb琳$S2_N~89CaUO{VNd*OY.ƙNAR߶r- 0h(MZv{XTf| /g(gΔH !m"g*\9YxWˆiqTFWvfv>"c۲.屫d'^xv#[o^B-?wƼa֜۝"YW*ZXTWm \іk VZV'_{jĽx'|C{.cc5~>dlJx!ݕ8yrߠ,PK!RTgdrs/downrev.xmlDN1E&CLhCd 1S ~ ]ܛss4L>hg%L)m+ b3z"Z$B֫%f6.V,AlPBcqʚ kɦ'iT97mzʯ]g$ty&b3C^ExҽWJ½XgN*KH~6_PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!vw8)drs/shapexml.xmlPK-!RTg5drs/downrev.xmlPK< ` \ oRespiratory Management Evaluate SNP as a criterion for NIV initiation. Evaluate the impact of early NIV initiation on survival and quality of life. Assess the impact of executive dysfunction on NIV compliance. Evaluate the effect of hypoventilation on executive dysfunction. Compare techniques for clearing upper airway secretions at various stages of respiratory and bulbar dysfunction. Evaluate pulmonary tests, compliance with NIV, and outcomes in patients with bulbar dysfunction. T rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 (  (   x`R0e0e?Rectangle 2@  \ \Future Research, cont.   1    xR0e0e?Rectangle 3"îPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!"D"drs/shapexml.xmlZ]o6}@uH·Eb #0{,h5KFҎKʒkm)xI^sHIx3ƦZEM3b>ﮏ9NDdZɈo?pQmX~sEղ\¾хTi oFZp(ZvTRI16d7ainw3%r {+cqIJD  F<%Ĉp/S9Ƙz8h0"t|XBX9sQNu~;n;)gtPb~2n} ѧ0󧂄:#gF`V0W]dB䬃٭֨e>ԙGFFq̡C cԤɑRֿ S02HݍE!X#Tw}}1@dMyJH0 F^|'O.(gH ҭ![R`Gs~rF"29cݡ ~+L+wL5;^=!O"ǎҦ?Ǖ+=.gw%rGy._j rYO &r --tS;8l|, h+a/};g>9a0m1PK!drs/downrev.xmlDN1E&CLiB0l=괝.o͹9yoZv$)mk r ,D [gI™g7S̕;قX!G M]y2#c)M3!ܠ~6#a-00}Q~(̵C}* #1?;U!m2>PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!"D")drs/shapexml.xmlPK-!drs/downrev.xmlPK ` \ Breaking the News Validate measures that can be applied to studies of diagnostic disclosure. Evaluate attitudes of neurologists and patients to strategies for breaking the news. Conduct controlled studies of the effects of different disclosure strategies on patient satisfaction, preserving hope, and outcomes. Multidisciplinary Clinic Examine referral bias to clinics. Examine factors essential to benefits in clinics, optimal visit frequency, cost effectiveness of staff, and economic factors in care. ~(( rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"h7 w_(  (   xR0e0e?Rectangle 2@  \ \Future Research, cont.      x@R0e0e?Rectangle 3 ` \ 7Symptomatic Management Conduct controlled trials of pharmacologic therapy for spasticity, cramps, constipation, sialorrhea, pseudobulbar affect, pain, depression, anxiety, fatigue, and therapeutic exercise. Examine irradiation and botulinum toxin for sialorrhea in controlled trials. Cognitive and Behavioral Impairment Develop consensus criteria for cognitive and behavioral impairment to ensure consistency in diagnosis and research. Identify screening tests for cognitive and behavioral impairment. Evaluate the natural history of, and treatments for, cognitive and behavioral impairment, and their impact on compliance and survival. &@%>  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"`7 w o W (  (   xR0e0e?Rectangle 2@  \ \Future Research, cont.       x R0e0e?Rectangle 3"lfPK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK! \drs/shapexml.xmlYn6;Y;^FEb m#0,z,hUSJҎSߡo'7l)`Ґ3RՇmFZw]ΤNMDŽ|=y3 I?v2Kaҥ,{gJѶ0E)tR{1Q:nS\қY9$wey~wp3- L{/S${;^"`Ĥ+W#^cLf<|aG WN1/1<-UcN0podKd~Wʹvoa}o_gUj_| zĐFOwgΞW33~?`-f^c2B5ឳ(=J蝚~geJKi"lHD'wf b3qPmbQqLH0 fQ O!$|G>6\gX ?]]P`,1=W! =)DUFe. u3MZT8CJKa]Fu5e,HE*-ZҔT, E\Br[ +XIF$6RqAgTQe@N18~S BԒrDWiJ!䜅Ha>Q q1F4C$q62"Dy F`,-'EA" 69po!RFyROt: ^?#u_>Բ /*}Y׀TY7+Qbt`{.lυ\,Φ _{ox_{|[>c| mlƕHrBpRSLR{FeL\(o@$^>miqO:m׈ַaQly3N[1,RwˀE~L PK!Fdrs/downrev.xmlDN0DHHܨM*VT($p8ۑ)_G3zXgG ND#\+a۬ńNcI8Sj'WѱN-K`RJΣ2d1N@.w{,CuS۞Osz1냕[7a,}Uۛ X1UL]FKx|l~ޅNW /fS_PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-! \)drs/shapexml.xmlPK-!FUdrs/downrev.xmlPK[ ` \ Communication Validate criteria to examine communication strategies. Design clinical trials to compare different strategies for communication in ALS. Palliative Care Design controlled trials of terminal symptom management, advanced directives, hospice, and spiritual care. tnn rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"7 *" (  !   xR0e0e?Rectangle 2@  \ UAcknowledgments      xR0e0e?Rectangle 3 ` \  The authors thank Gary Gronseth, MD; Thomas Getchius; Valerie Cwik, MD; Larry Brower; and Sid Valo for contributions to the practice parameters; Christina Metzler and Barbara Phillips, MS, OTR/L, for their contributions to the patient summary versions of the guidelines; and Sharon J. Matland, RN, MBA, for her contributions to both the practice parameters and the patient summary versions. .  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"Z7 qi Q(     xR0e0e?Rectangle 2@  \ P References        x R0e0e?Rectangle 3" PK![Content_Types].xmlJ0*miG]`Hm6 Xwt?. g#Wi3E).+7 >ON ޑ1ˋz "+R RhB.} /<^ITխ%rHK4uK~I0xM e`|X}đ I`߽N4aG2$RKIZ)4(M9`ctB{m:f@`3n|O,ܗr޾jxR0T ,0@}WBLǬ5vPK!Ofdjdrs/shapexml.xml]n6}/Zd\wcY$0#΢ Zc5Ri/ċ&dDrMN>[rGEn.w>^Y ><Ì樴Z# P  4 T>޽dUׂI{9=8߃G):E,4֒a"@C_q^(;Hd1R]2Lf9U:k劤Z^#J$D=@/ A./ME'$LcߵBm},b M'V$vep6NǟB(SQm"@&}-˘$O˳`(oHa}I8l5)YFq6SE"7+-bX:/QsP"haM`eTF6PljZ@P8fl`."\|TAGQ."K&;T;.EMAW=ߴTGd5m,ta$Ճv剺9)RcAW^Fqlڹ 8 )hrLg3B:B]P2֭(/؉-gk !An4bWgyS4\[.a`λi0!!EϭSKw0w #Q .F$Lpwl˜,Gqq7qM&IXR Ŷ)Kl*ܰoncZ"cXO9vZq./c r* >g/Kȣ9^YX ~ *n/1`F6 G̳PK!drs/downrev.xmlDOO1G&~fLI b$-۰vvX68y˛{Ӳ 4VNi[K8 *l% 7 0M1Wj c͒Ć%41v9j`lb' t+$7-τxM vP? G(W¼,Gqۗ珅X>?ﶋWQ%i};z r>PK-![Content_Types].xmlPK-!1_a ._rels/.relsPK-!Ofdj)drs/shapexml.xmlPK-!drs/downrev.xmlPK  ` \z___PPT9\T Miller RG, Rosenberg JA, Gelinas DF, et al. Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the ɫ: ALS Practice Parameters Task Force. Neurology 1999;52:1311-1323. Bourke SC, Tomlinson M, Williams TL, Bullock RE, Shaw PJ, Gibson GJ. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 2006;5:140-147. Kasarskis EJ, Scarlata D, Hill R, Fuller C, Stambler N, Cedarbaum JM. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials. J Neurol Sci 1999;169:118-125. Numico G, Anfossi M, Bertelli G, et al. The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancer. Ann Oncol 2009. 5. Molloy L. Treatment of sialorrhea in patients with Parkinson's disease: best current evidence. Curr Opin Neurol 2007;20:493-498. Abbruzzese G. The medical management of spasticity. Eur J Neurol 2002;9 Suppl 1:30-34; discussion 53-61. " j" " +i    rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +" 7 "  0 (     x`R0e0e?Rectangle 2@  \ P References        xR0e0e?Rectangle 3 ` \___PPT9d\ TAndersen PM, Borasio GD, Dengler R, et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. Eur J Neurol 2005;12:921-938. O'Mahony S, McHugh M, Zallman L, Selwyn P. Ventilator withdrawal: procedures and outcomes. Report of a collaboration between a critical care division and a palliative care service. J Pain Symptom Manage 2003;26:954-961. Lanken PN, Terry PB, Delisser HM, et al. An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 2008;177:912-927. Miller RG, Anderson F, Neelam G, Wei Hea. The ALS Patient CARE Program-Northern American Patient CARE Database. In: Mitsumoto H, Przedborski, S., Gordon, P.H., ed. Amyotrophic Lateral Sclerosis: Taylor & Francis Group, 2006: 633-648. For a complete list of references, please access the full guidelines at www.aan.com/guidelines " " _" " _  *      7 rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"Y7 ph@P(  $   xz 0e0e?Rectangle 2> \ XQuestions/Comments   rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"h7 wP_(  3   x{ 0e0e?Rectangle 2> \ g!Thank you for your participation!" ""  rB  J>?Line 4rB  J>?Line 5   33y___PPT10Y+D=' = @B +"r`Y 32%4W;\rbhmt{A0Mݲ[XD&?*UG ngR"(.4:JY_o}wG+q  !&7=N-TZio~Äsk0GF TQ J/+5CIJX1^lrhqQ!#z&)vUiOh+'0 hp  < H T`hPPractice Parameter or Technology Assessment: TITLE (an evidence-based review)jcoxSlide set templateRachel White974Microsoft Office PowerPoint@ww@jAI@r"= G;  pp  @pA x@(xkskkkkkkkskkkkkkkskkkkkkssss{{{{ƵƵƽƽƽƽƽƽƽƵƽƵ{{{{{{{{sss{sssskksskkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkkkskkkkkksskkkkkksskkkkkksskkkkkkkkkkJk)JJ)19))kJZk99J)1c11!!11!cs!R9!!9!!!sc!ZBZ{!BBƽ)c))))sJJ)sR)ֵƽƽƽƽƽƽƽƽ{{{{{{ss{{sssskssskkkkkkkkkkkkkkkkkkkkkkkskkkkkkkskkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkkk{kkkkkkkkkkkkkkkkkkkkkkkkkkkssss{{{{ƵƵννƽννƽνƵƵƵ{{{{{{ss{ssssskksskkkkkksskksskksskksskksskksskksskksskksskkskkkkkkkkkkkkkkkkkc{ckkc{ckkc{cccc{cc{ccscc{ccsZc{cZsZcscZsZZsZZkZZsZRkRZkZRkRRkRRcRkkkkkkkkkkkkkkkkkkkkkksskkss{{{{{{ƽƽƽƽνƽƽƵƵƵ{{{{{{ss{{sssssssskkskkkkkkksskksskksskksskksskksskksskkkskksskkkkkkkkkkkkkkkkkkkkkkkkkckkkkkkc{ckkc{ckkc{ck{kc{ck{kc{cc{cc{cc{ccscc{ccscc{ck{kksk{kkkk{kkkk{kkkk{kksk{kksk{kssksssss{{ss{{{{{{{{{{{{{{{{{{s{{{s{{{sss{sss{ksssksssk{kssk{kksk{kkkk{kksk{kkkk{kksk{kk{kk{kkkk{kkkk{kksk{kkkk{kksk{kkkk{kkkc{kkkk{kkkk{kkkk{kksk{kkkk{kkkk{kkkk{kkkk{kkkk{kkkk{kkkk{kkkk{kkkk{kksk{kk{kZ{1ZޜR1{RޜRR{{R޽1{R{{޽RޜR{{{{1{RR{ޜ{1{{ޜޜRRRR{1RޜR{{޽1{{1{{޽RޜRR{{1{1111{{1{{{1{RRޜRޜޜRR{1ZZޜ眜RZޜ{Z{R{RZZ111RZZR眜ZR{{{{{{{Ɯ1{1111{{1{{{1{1{1{{޽RޜRZRZޜRRޜRRޜޜR1޽{RRޜRRRRޜRR1޽{1{{1޽޽R{޽{޽{{{{{RޜRRޜR眜ZRR眜ZR眜ޜ{RRR{{{RRR{{R޽{1޽1{R{{޽ޜ{RR1{111R11RRR{R1{1{{11{RޜޜRRRR{1ޜޜRR{1ޜ{RRR{{{RRR{{R޽{11{{1{{޽RޜR{11111111{1{R{{{ޜޜRRRR{1RޜRRR1{{1޽ZR{{{{{ޜZ{RRƜ眜RR1{111{R1{RZZ1{{11{1{{11{RRRZޜRޜRZRZޜZR{{{{{ޜZ{RRƜޜ{{ZRR111111111ZRR{Z{R{Z{RRRZޜRZޜZR1{ZR1{RRޜޜRRRRޜޜR{11R޽{ޜ{{ޜޜRRޜRRRRޜRRޜRRޜRR1{RRޜޜRRRRޜ1{{1R1޽{RޜRRޜRRRRޜRR1޽{R1޽{RޜRޜRޜRR1{{R1{RZޜZ{11{1Z{{1RZRޜޜRRRR{1ZZ{{ƜZ{11{1{1{1{RޜRRRR{11{Z{{ZZ{{ޜRޜ{11{ZR{R1Z{1眜ZZZZ{1ޜƜ{{ޜRRRZ{1R{1R{ZR{11RZ{Z1RZޜ眜ZZZZ{1{1{RRRRRR111{RRR{1RRRRRޜRRRޜRRޜRR1{1{1RRޜRRRޜޜRRޜRR1{1{R1R{RRRRޜR{1RR{RRR{1R{R{{RR1111RR11RRޜRRRޜ眜ޜޜZZޜZZRRޜRZ1{眜Z{1ޜ{{ZZޜZZRRޜRޜZ1{ޜR{1眜RRRRZZZޜƜZZޜZZRޜRRRRZZZRZޜR{1޽ZR眜ZޜޜRRRR{1ޜޜRR{1ޜ{RRR{{{RRR{{R޽{1޽1{R{{޽R{1{{޽RޜR{ޜ{1R{{{11{RR{11RޜޜRRRR{1ޜ{RRR{{{RRR{{R޽{1R{1{{޽1{R{R1{{1{{11RR{{R{{ޜRޜޜRRR޽{1RޜRR{޽{{{޽RRZޜZZRZR眜RZ{{{ޜ{{ƜR{ZZ眜ޜޜZZR1111{{11{RZZ111RRRZޜZR{{{{{ޜZ{RRƜ眜眜Z111RZZZR1111R{Z{{ZZR{ZZ{{{{{眜RRޜRRRRޜRRޜRRޜRR1{RRޜޜRRRRޜޜRޜRR1޽{޽ޜ{{ޜޜRRޜRRRRޜRR1{RRޜޜRRRRޜRޜRR1޽{ޜR{1RRޜ޽޽R{޽{RR眜RZ眜RޜޜRR{{޽1{{1{{{޽ޜRR{R{{{{{{1{RRޜRRRR{1ޜ{RRR{{{RRR{{R޽{11{{1{{޽RޜR{{޽1{{R1{111{1R{{RRR1RR11RRRޜޜRRRR{1ޜ{RRR{{{RRR{{R޽{1RޜR{{޽1{R{{޽ޜRޜ{11{111R11RR{R1{{1R{{{RR{{1{{1޽ZZޜ{{ZZ{R{{{{{{1{R1ZZ޽{RRZޜZR{{{{{ޜZ{RRƜޜ{{ZZ{1{111Z1{R{Z11{{Z1{ZRRZޜZZR眜ZR{{{{{ޜZ{RRƜZZޜZR1{111{Z1{ZRRR1{R1{1{ZR{1RRRRޜRRR{{{{{RRޜRRRRޜRR1{RRޜޜRRRRޜ1{{1R1޽{ޜޜRRޜRRRRޜRR1{RRޜޜRRRRޜR1޽{ޜޜR޽{1ޜRR{11{R1{{1{{ޜ{{ޜ{{111{{11{{1RR{ޜ1{{1{{{1{{11{{{RR1ޜR1{ޜ{{R{{ZZޜ{{ƽޜ{Z{R{{1Z1{R1{{ZZ{ޜ{{Z{RR1{Z1{ƜR{{{{{{RR1R1Rޜ{{R{{޽{{{1{{1{{{޽{{R{{1R{{1{{{R{{1R{R{{R޽{R{޽1{ƜR1{ƽ{1{{{{1{R1{{11{{1R{{11{{11{{1ZZ{ޜ{Z{޽{{RR{R{Ɯ{{ZZ1{{{11{{11{{11{{1޽1{{1{{1{{1RRRR1{{{1޽{R{ƽ{Z{RR{{R{Ɯ{{1{{1RR{RR1{{{1R{RZZZޜZZޜ{R{ƽ{Z{1{{1Z{Z1{{{11{{1RR{{R{Ɯ{{R1{޽1{R{{޽{{{{{޽1{{1޽ޜ{{R{R11ޜ{R{޽{{RRޜ{R{޽{{RR{{{ޜ{{ޜ1{1޽{޽ޜ{{R{{RRޜ{{ޜRRޜ1R111޽{1{ޜRRRޜ{R{޽{{{1{1R11ޜ1R{R1޽1{1R11RRRޜRRޜ1{R{R{޽1{1111{R1޽{1R1R11ޜ{R{޽{{{{{ޜ{Z1{{{޽{{R{{11{{1R{{1Z{{1R{1ZZRRZRZ1{{11{{1޽ZZ1R1RRZR{11{{1޽{{RRR{11{{1R{{1RR{1{{{1R{{1Z{{1޽{{RR1{{1Z{{1R{{11{{1R{{1{{޽{Z{޽1{{1RRޜޜ{{ޜ{{ޜ1{R{{ޜRRޜR{1ޜ޽R{1{{޽RR1RR޽{1{R{{ޜ11{1ZZ{1R{ƜZ{R{1{{1RR{1{{11{{1{{1{{1RRRR1{{{1޽{1ޜR1{{1R{R{{ZRR{1{{{1R1{1{{11{ƽ{1ZZRRRRR1{{{1R{RZZZޜ1{{1R{R1{R1{1{R1޽1{RR{R11ޜ{{ޜ޽ޜ{{R{{RRޜ{{ޜRRޜ1R111޽{RRޜRޜR{{޽{{1{1R11{{RRR{{{{ޜ{{{ޜ{޽1{R{{ޜ1{1R11RRRޜ1R{R1޽1{1R11RRRޜ{R{޽{1{1{{ޜ{R11{{1R{{1Z{{1R{{1R{ZZZ1R1RRZR{11{{1޽{{{ޜ{{{޽{{R{{1{{{RR{ZZޜR{{޽{Z{޽Z1{ZޜRZ{1R{{1Z{{1R{{1Z{{1Z{{1R{R1{{1޽{{ޜ1{R{{ޜRRޜRRޜ{{{{ޜ1{{1{{ޜ{{޽{{޽{Z{޽{Z{޽޽1{ޜRRRRޜR{1{1RRޜ{11{1{ޜRR޽R1{ޜR{޽{1{{1R{޽{{޽{R{1{1{11޽{RޜR1{111ޜR{1{1R{޽{{޽{RRR{1{1R{111޽{1{{11{ޜR{1{11{111ޜRRRޜ{1{1{11޽{RޜR{1{1{1R޽RRޜ{ޜ{{1ZR{{RZRRRRRR眜ޜZZ{1ZRZ{1ZRRRRR{1R{{{{ZRR1{ZZZ{1Z眜RZZ1{ޜRZZޜZ{޽{{{RZ{޽{ZZޜZ{޽{RRZZޜZ{1{1RZZޜޜZZ1{ޜRZZޜZZޜ1{RRR{1RZRRRZ11{{ZZ{ޜRRR޽1{ޜRR{޽{޽RޜRRR1R޽{RRޜ{RR1{ޜRR޽R1{ޜRRRޜ{R{1R{޽{{޽{RRRRRޜRRRޜRRRRޜRRRR{޽{{޽{RR{޽{޽RR1{{11{ޜRޜRR{R{11{ޜRRRRRRRޜR1R޽{RRRRޜRRRޜRRRRR{{R{{{{ޜRRRZ{1{1RZ{11{1RZ11{11{RZRZRZ{{RZ1{Z{11{RRRRZޜR1{ZZZޜR{11޽{1{ޜR{1{1{11޽{{{RRޜRZޜRZޜR{11޽{1{ZZZޜR1ZR11{Ɯ11{ZZZZRZ{11{{R{RR{R{{ޜ{RޜRRޜRޜ{1R޽RޜRRޜR{{ޜRޜRRޜR޽{R{޽R{޽{R{1R{޽{{11޽{ZޜRZ{1Z{޽{{{R{1{11{ޜR1{{1Z{1ZޜR{1{1Z{޽{{{RZ{1ޜ{1RRRRZR{1R{{{{Z1{{1R{{{{ޜZZ{Z{޽{11޽{Z{1ZZ{ޜ{11޽{1{ޜRZ{޽{{{RZޜRRRZޜR1{{1Z{1{1{1ZZޜ1{{1ZޜRRRޜޜRRRޜR{޽{R{޽{{޽{RRRޜR{޽{ޜRRRRޜR޽{1{޽{RޜRRRޜR{޽{{޽{R{޽{RR11{{RR{ޜRRޜR{޽{R{޽{{޽{RRRޜR޽{1R{޽{{ޜ{ޜRRR1{޽{RRޜޜRR{޽{RRޜRRޜޜRRR{޽{ޜRRR{޽{{޽{RRޜRR{޽{RޜRRRޜR޽{1{޽{RRޜRRޜRRޜR޽{1RޜRZZޜRRZޜR{޽{1{ޜR{{RZR1{ޜRRR{R{1{޽{ZޜRZRZ{޽{{{R{޽{ZZ{{Z{{{{RZ{{1{Z{{Z{Z{11{{1{ޜZ1ޜZZ{ޜ{{{ZZޜRR{޽{1Z޽{ZZޜRR1{ޜRRR1{ޜR{{RZޜRZ{޽{罽ZޜR{R{1{޽{ZR1Z޽{{R{1ZޜR{11{1{Rޜ1{{1R{11ޜR{11޽{R{11ޜRRR1{{1RޜR{11޽{1{R1{{1޽{R{޽RRޜ{R{RR1{{1R{11ޜRRޜRR{1RR1R{{{1{{޽{{{11{1{{11R{R11{11޽{R{11ޜRR{11ޜRRޜR{1{1RޜRRR1{{1{11޽{1RR11RޜRRޜRZ1{{޽{Z{޽{{޽{ZޜR{޽{RZ{{R{{{޽{Z{޽{ZޜRZޜR{޽{ZޜRR{޽{RZZZޜ1{{1RRZ{1ZޜRRR{1{1ZޜR1{{1RR1{{1R{{{{ޜZZ{1{1R{1{1{1RRR11{Z1{Z1{111Z1{{1R{1{1{1RZ{R{Z{޽{{{R{1{1ޜRR1{{1ZZޜ{1{1RޜRRRޜRRޜR޽{1R{޽{{޽{RޜRR{޽{RRޜRޜRRRޜR޽{1RRޜRRޜR޽{1R{޽{{ޜ{ޜRRRRޜ{޽{RRޜRRޜR{޽{R޽{1R{޽{RRRRR1{ޜRRRޜR޽{1{޽{RRޜ޽{R{޽R{޽{{޽{RRRޜR{޽{RRޜR޽{1RRޜRRޜRޜR1Z޽{{R{1Z{޽{罽{޽{ZޜRZ{޽{罽ZRZZ{Z{11R{{Z{11{{1{ޜZ1ޜZZRZ{{RZ1R{R{{{{Z1{ZZZZRRRZ{Z{1{{RZ{R{1{ޜR{{RZRZ{޽{罽{R{11Z޽{ZRRޜRޜޜRR1RR11RޜR{1{11{{1RޜR{1{1{11޽{RޜRޜޜRRRޜR1RR11RޜRR{1RR1R{{{1{11{1{{1{11޽{1RR11ޜR{޽{{޽{RR{11ޜR1{RRRޜRRR1{{1{11޽{RޜR޽{R{޽R{11ޜR{11޽{{1{1RޜR1RR11{11޽{RޜR{޽{ZޜRZZ{{RZ{{1{{1Z{޽{9ssss{{{{ƽƽƽƽƽƽƽƽƽƽƽƽƵ{{{{{{{{{{{{{{ss{{ss{{ss{{sssssssskssskksskkkkkkkkkkkkcckkccckc{cccc{cccZ{cccc{cccc{cccc{ckk{s{{ƽƽƽƽƽƽƽƽƽƽƽƽƽ{{{{{{{{{{{s{{sssssssssssskksskkkkkkkkkkkkc{ckkc{cc{cc{cc{cc{cc{cZsZc{cZsZZ{cZsZc{cZsZZ{ZZsZZ{c{{{{ƵƵνƽƽνƽƽνƽƽƵƽƵƵƵ{{{{{{{{{{{{ss{{sssssssskkssk{kksk{kk{kc{ck{kc{cc{ccscc{cZsZcscZsZcsZZkZZsZRkRZkZRkRZkZRkRZkZRkRRkRRcRss{{{{ƵƽƵνƽƽνƽƽνƽƽƵƽƵƽƵƵ{{{{{{{{{ss{{ss{{sssssssskksskkkkk{kkkc{ck{kc{cc{ccscc{cZsZcscZsZZscZkZZsZZkZZsZRkRZkZRkRZkZRkRRkR{{{{ƽέƵֵƽƽνƽƽνƽνƽƽƵƽƵƽƵ{{{{{{{{{{{{sss{sssssssskksskkkkk{kkkc{ck{kc{cc{kc{cc{cZsZc{cZsZZscZsZZsZZsZZsZZkZZsZRkZss{{{{s{s甔sssΜƽƽƽƽƽƽƽƽƽƵƽƽƵƵ{{{{{{{{{{{{ss{{sssssssskksskkssk{kkkk{kkkc{ck{kc{cc{ccscc{cZsZc{cZsZZsZZsZZsZZkZZsZZkZZsZ{{{{{{ƽƭνֽνƽƽƽƽνƽƽƽƽƵƽƵƵ{{{{{{{ss{{ss{{sssssssskksskkkkk{kkkk{kk{kc{ck{kc{cc{ccsZc{cZsZc{cZsZc{cZsZcscZsZss{{{{ƜƽƵνƽνƽƽνƽνƽƽƵƽƵƵƵ{{{{{{{{{{ss{{sssssssskksskkssk{kkkk{kkkc{ck{cc{cc{ccscc{ccsZc{cZsZc{cZsZc{cZsZZsc{{{{Z{cƥƽƥνƽνƽƽƽƽƽƵƽƵƽƵƵƵ{{{{{{{{{{ss{{sssssssskksskkkskkkkkkkkc{ckkc{cc{cc{cc{cc{cc{ccsZc{ccsZss{{R{cR{kƽƽνƽƽƽƽƽƽνƽƽƵƽƵƽƵƵ{{{{{{{{s{{{ss{{sssssssskksskksskkkkkkkkc{ckkc{cc{cc{cc{cc{cc{cZscc{cZsZc{c{{{{kR{Z{{ƽƽνƽƽƽƽνƽνƽƽƵƽƵƵƵ{{{{{{{s{{{ss{{sssssssskksskkkkkkkkkkkkc{ckkc{ckkc{ckkc{cc{cc{css{{{{s{ƵƵνƽνƽνƽƽνƽνƽƽƵƽƵƵƵƵ{{{{{{{{{s{{{ss{{sssssssskksskksskkkkkkkkc{ckkc{ckkc{cc{cc{cc{cc{cc{c{{{{ƵƵννƽνƽννƽνƽƽƵƽƵƽƵƵƵ{{{{{{{{{ss{{ss{{sssssssskksskkkkkkkkkkkkcckkcckkc{ckkc{css{{ƵƵννƽƽƽƽƽƽƽƽƽƵƽƵƽƵƵ{{{{{{{{{{{{{{{ss{{sssssssskksskksskkkkkkkkc{ckkcckkc{ckkc{ckk{{{{ƵƵννƽνƽƽνƽνƽƽƵƽƵƵƵƵƵ{{{{{{{{{{{{ss{{sssssssskksskkskkkkkkkkkkkkkkkkkkcss{{{{ƽƽƽƽƽƽƽƽƽƽƵƽƵƽƵƵ{{{{{{{{{{{s{{{s{{{sssssssssssskksskkkkkkkkckkkckkkc{ckkcckkc{ckk{s{sƽƽƽƽƽƽƽƽƽƽƽƽƵƵ{{{{{{{{{{{{{{s{{ss{{sss{sssssssskssskksskkkkkkkkkkkkcckkkkkkckkkkkss{{{{ƵƽƽƽƽƽƽƽƽƽƽƽƽƽƵƵ{{{{{{{{{{{{{{{ss{{ss{{sssssssssssskkskkkkkkkkkkkkkcckkccckc{cccccccc{ccccccc՜.+,D՜.+,p   ( 0 On-screen Show (4:3) ɫ' Ds uArialSlide set templateqPractice Parameter update: The care of the patient with amyotrophic lateral sclerosis (an evidence-based review)#The AAN develops these presentation slides as educational tools for neurologists and other health care practitioners. You may download and retain a single copy for your personal use. Please contact guidelines@aan.com to learn about options for sharing this content beyond your personal use.Presentation Objectives Overview Background Gaps in CareAAN Guideline ProcessClinical QuestionsPowerPoint Presentation AAN Classification of EvidenceAAN Level of Recommendations%Translating Class to Recommendations,Translating Class to Recommendations, cont.#Applying This Process to the IssueClinical QuestionsClinical Questions, cont.Clinical Questions, cont.Clinical Questions, cont.Clinical Questions, cont.MethodsMethods, cont.Methods, cont.Methods, cont.Literature Review<AAN Classification of Evidence for Therapeutic InterventionCAAN Classification of Evidence for Therapeutic Intervention, cont.CAAN Classification of Evidence for Therapeutic Intervention, cont.7AAN Classification of Evidence for Diagnostic Accuracy>AAN Classification of Evidence for Diagnostic Accuracy, cont.Analysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of Evidence ConclusionsRecommendationsAnalysis of Evidence ConclusionsConclusions, cont.RecommendationsAnalysis of EvidenceConclusions/RecommendationAnalysis of Evidence ConclusionsRecommendationsAnalysis of EvidenceConclusions/RecommendationAnalysis of Evidence ConclusionsRecommendationsClinical ContextAnalysis of EvidenceConclusion/RecommendationClinical ContextAnalysis of EvidenceConclusions/RecommendationsAnalysis of EvidenceConclusions/RecommendationsClinical ContextAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationClinical ContextAnalysis of EvidenceConclusion/RecommendationClinical ContextAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationAnalysis of EvidenceConclusion/RecommendationClinical ContextClinical ContextClinical ContextClinical Context, cont.Clinical Context, cont.Future ResearchFuture Research, cont.Future Research, cont.Future Research, cont.Future Research, cont.Future Research, cont.Acknowledgments References ReferencesQuestions/Comments"Thank you for your participation!  Fonts UsedTheme Slide Titless 8@ _PID_HLINKSAmailto:guidelines@aan.comhttp://www.aan.com/guidelinesmailto:guidelines@aan.comhttp://www.aan.com/guidelines$_+ 7Rachel WhiteRachel White  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root EntrydO)PicturesCurrent UserSummaryInformation((PowerPoint Document(~+DocumentSummaryInformation8